Hospitalization

• 

  Subject Areas on Research

  • "Code stroke": hospitalized versus emergency department patients. 
  • "I'm Trying To Be the Safety Net": Family Protection of Patients With Moderate-To-Severe TBI During the Hospital Stay. 
  • 18-Fluorodeoxyglucose positron emission tomography in children and adolescents with traumatic brain injury. 
  • 1918 Influenza Pandemic: In Utero Exposure in the United States and Long-Term Impact on Hospitalizations. 
  • 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials. 
  • 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. 
  • 3-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter Aortic Valve Replacement. 
  • 30-day mortality and readmission after hemorrhagic stroke among Medicare beneficiaries in Joint Commission primary stroke center-certified and noncertified hospitals. 
  • A Critical Appraisal of Short-Term End Points in Acute Heart Failure Clinical Trials. 
  • A Hospital Level Analysis of 30-Day Readmission Performance for Heart Failure Patients and Long-Term Survival: Findings from Get With The Guidelines-Heart Failure. 
  • A MUC5B Gene Polymorphism, rs35705950-T, Confers Protective Effects Against COVID-19 Hospitalization but Not Severe Disease or Mortality. 
  • A Nationwide Epidemiological Analysis of Finger Infections Presenting to Emergency Departments in the United States From 2012 to 2016. 
  • A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19. 
  • A Novel Rehabilitation Intervention for Older Patients With Acute Decompensated Heart Failure: The REHAB-HF Pilot Study. 
  • A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation. 
  • A Systematic Review and Meta-Analyses of the Association Between Anti-Hypertensive Classes and the Risk of Falls Among Older Adults. 
  • A brief depression scale for use in the medically ill. 
  • A case series describing causes of death in pregnant women with sickle cell disease in a low-resource setting. 
  • A comparison of the case-control and case-crossover designs for estimating medical costs of nonfatal fall-related injuries among older Americans. 
  • A comparison of the costs of and quality of life after coronary angioplasty or coronary surgery for multivessel coronary artery disease. Results from the Emory Angioplasty Versus Surgery Trial (EAST). 
  • A computerized physician order entry set designed to improve safety of intravenous haloperidol utilization: a retrospective study in agitated hospitalized patients. 
  • A controlled trial of inpatient and outpatient geriatric evaluation and management. 
  • A cost-minimization analysis comparing azithromycin-based and levofloxacin-based protocols for the treatment of patients hospitalized with community-acquired pneumonia: results from the CAP-IN trial. 
  • A critique of the effectiveness of assertive community treatment. 
  • A diagnostic and family study of posttraumatic stress disorder. 
  • A double-blind comparison of bupropion and amitriptyline in depressed inpatients. 
  • A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression. 
  • A hospital-based prevalence survey of bloodstream infections in febrile patients in Malawi: implications for diagnosis and therapy. 
  • A hospital-based treatment of suicide attempt patients with problematic alcohol use: Rationale and treatment development. 
  • A machine learning approach to identify distinct subgroups of veterans at risk for hospitalization or death using administrative and electronic health record data. 
  • A multicenter analysis of the ED diagnosis of pneumonia. 
  • A national study for regional variation of inpatient ECT utilization from 4,411 hospitals across the United States. 
  • A pilot study examining activity monitor use in older adults with heart failure during and after hospitalization. 
  • A pilot study of a structured interview addressing sexual function in men with schizophrenia. 
  • A pilot study of assertive community treatment for patients with chronic psychotic disorders. 
  • A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis. 
  • A population-level analysis of 5620 recipients of multiple in-hospital cardiopulmonary resuscitation attempts. 
  • A prospective study of cancer survivors and risk of sepsis within the REGARDS cohort. 
  • A protocol of early spiral computed tomography for the detection of stones in patients with renal colic has reduced the time to diagnosis and overall management costs. 
  • A randomized clinical trial to evaluate the efficacy and safety of rivaroxaban in patients with bioprosthetic mitral valve and atrial fibrillation or flutter: Rationale and design of the RIVER trial. 
  • A randomized controlled trial comparing two vaso-occlusive episode (VOE) protocols in sickle cell disease (SCD). 
  • A rapid evidence assessment of bleed-related healthcare resource utilization in publications reporting the use of direct oral anticoagulants for non-valvular atrial fibrillation. 
  • A retrospective study exploring the effects of intramuscular aripiprazole on QTc change in agitated medically ill patients. 
  • A risk score based on baseline risk factors for predicting mortality in COVID-19 patients. 
  • A smoker's paradox in patients hospitalized for heart failure: findings from OPTIMIZE-HF. 
  • A survey of stakeholder knowledge, experience, and opinions of advance directives for mental health in Virginia. 
  • A systematic review of randomized trials of disease management programs in heart failure. 
  • A tale of two trials: a comparison of the post-acute coronary syndrome lipid-lowering trials A to Z and PROVE IT-TIMI 22. 
  • A time-series analysis of the relation between unemployment rate and hospital admission for acute myocardial infarction and stroke in Brazil over more than a decade. 
  • A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. 
  • AHA scientific statement: practice standards for electrocardiographic monitoring in hospital settings: an American Heart Association Scientific Statement from the Councils on Cardiovascular Nursing, Clinical Cardiology, and Cardiovascular Disease in the Young: endorsed by the International Society of Computerized electrocardiology and the American Association of Critical-Care Nurses. 
  • AKI Treated with Renal Replacement Therapy in Critically Ill Patients with COVID-19. 
  • AKI in Children Hospitalized with Nephrotic Syndrome. 
  • APOL1 Risk Variants, Acute Kidney Injury, and Death in Participants With African Ancestry Hospitalized With COVID-19 From the Million Veteran Program. 
  • Ability of an antibiogram to predict Pseudomonas aeruginosa susceptibility to targeted antimicrobials based on hospital day of isolation. 
  • Abnormal resting regional cerebral blood flow patterns and their correlates in schizophrenia. 
  • Aborted myocardial infarction: a new target for reperfusion therapy. 
  • Accelerometer-Measured Hospital Physical Activity and Hospital-Acquired Disability in Older Adults. 
  • Acceptance of rapid HIV testing among medical inpatients in New York City. 
  • Access to multiple sclerosis specialty care. 
  • Access to routine care and risks for 30-day readmission in patients with cardiovascular disease. 
  • Accuracy of Medical Claims for Identifying Cardiovascular and Bleeding Events After Myocardial Infarction : A Secondary Analysis of the TRANSLATE-ACS Study. 
  • Achievement and quality measure attainment in patients hospitalized with atrial fibrillation: Results from The Get With The Guidelines - Atrial Fibrillation (GWTG-AFIB) registry. 
  • Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the Acute Cardiovascular Care Association of the European Society of Cardiology. 
  • Acute Heart Failure: Alternatives to Hospitalization. 
  • Acute Limb Ischemia in Peripheral Artery Disease. 
  • Acute and 1-Year Hospitalization Costs for Acute Myocardial Infarction Treated With Percutaneous Coronary Intervention: Results From the TRANSLATE-ACS Registry. 
  • Acute cardiovascular hospitalizations and illness severity before and during the COVID-19 pandemic. 
  • Acute childbirth morbidity: its measurement using hospital charges. 
  • Acute decompensated heart failure: update on new and emerging evidence and directions for future research. 
  • Acute heart failure in elderly patients: worse outcomes and differential utility of standard prognostic variables. Insights from the PROTECT trial. 
  • Acute heart failure in the elderly: differences in clinical characteristics, outcomes, and prognostic factors in the VERITAS Study. 
  • Acute heart failure in the young: Clinical characteristics and biomarker profiles. 
  • Acute kidney injury and cardiovascular outcomes in acute severe hypertension. 
  • Acute myocardial infarction complicated by atrial fibrillation in the elderly: prevalence and outcomes. 
  • Acute renal failure in hospitalized patients with HIV: risk factors and impact on in-hospital mortality. 
  • Adenocarcinoma of the prostate: an expensive way to die. 
  • Adequate health literacy is associated with higher heart failure knowledge and self-care confidence in hospitalized patients. 
  • Administrative Codes for Capturing In-Hospital Cardiac Arrest. 
  • Administrative claims data to support pragmatic clinical trial outcome ascertainment on cardiovascular health. 
  • Admission Psychosocial Characteristics of Critically Ill Children and Acute Stress. 
  • Admission heart rate and in-hospital outcomes in patients hospitalized for heart failure in sinus rhythm and in atrial fibrillation. 
  • Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF). 
  • Admission oxygenation and ventilation parameters associated with discharge survival in severe pediatric traumatic brain injury. 
  • Adoption of a national antimicrobial guide (SWAB-ID) in the Netherlands. 
  • Advance Care Planning Claims and Health Care Utilization Among Seriously Ill Patients Near the End of Life. 
  • Advanced heart failure patients supported with ambulatory inotropic therapy: What defines success of therapy? 
  • Adverse drug events in high risk older outpatients. 
  • Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. 
  • Adverse health outcomes after discharge from the emergency department--incidence and risk factors in a veteran population. 
  • Age differences in care practices and outcomes for hospitalized patients with cancer. 
  • Age differences in the use of implantable cardioverter-defibrillators among older patients hospitalized with heart failure. 
  • Age- and gender-related differences in quality of care and outcomes of patients hospitalized with heart failure (from OPTIMIZE-HF). 
  • Age- and sex-specific predictors of inpatient rehabilitation facility discharge destination for adult patients with traumatic brain injury. 
  • Age-related differences in biomarkers of acute inflammation during hospitalization for sepsis. 
  • Age-related differences in care preferences, treatment decisions, and clinical outcomes of seriously ill hospitalized adults: lessons from SUPPORT. 
  • Airborne Fine Particles and Risk of Hospital Admissions for Understudied Populations: Effects by Urbanicity and Short-Term Cumulative Exposures in 708 U.S. Counties. 
  • Aldosterone antagonists--last man standing? 
  • Alternative Payment Models and Associations With Stroke Outcomes, Spending, and Service Utilization: A Systematic Review. 
  • Ambulatory care connections of Medicaid-insured children with sickle cell disease. 
  • An Assessment of Bleeding Complications Necessitating Blood Transfusion across Inpatient Plastic Surgery Procedures: A Nationwide Analysis Using the National Surgical Quality Improvement Program Database. 
  • An assessment of medical resource utilization and hospitalization cost associated with a diagnosis of anemia in women with obstetrical bleeding in the United States. 
  • An educational intervention to improve internal medicine interns' awareness of hazards of hospitalization in acutely ill older adults. 
  • An evaluation of outcomes in patients with traumatic brain injury at a referral hospital in Tanzania: evidence from a survival analysis. 
  • An integrative review on screening for frailty in acute care: Accuracy, barriers to implementation and adoption strategies. 
  • An international perspective on hospitalized patients with viral community-acquired pneumonia. 
  • Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved. 
  • Analysis of the North Carolina long-term care polypharmacy initiative: a multiple-cohort approach using propensity-score matching for both evaluation and targeting. 
  • Analyzing change in recovery patterns in the year after acute hospitalization. 
  • Androgen deprivation therapy and depression in men with prostate cancer treated with definitive radiation therapy. 
  • Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function. 
  • Aneurysmal Subarachnoid Hemorrhage in Patients with Coronavirus Disease 2019 (COVID-19): A Case Series. 
  • Angina and Future Cardiovascular Events in Stable Patients With Coronary Artery Disease: Insights From the Reduction of Atherothrombosis for Continued Health (REACH) Registry. 
  • Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction. 
  • Annual direct and indirect health costs of the congenital ichthyoses. 
  • Anorexia nervosa--thinness as illness. 
  • Anorexia nervosa: a combined therapeutic approach. 
  • Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial. 
  • Antibiotic Prophylaxis for Infective Endocarditis. 
  • Anticoagulant Therapy in Patients Hospitalized With COVID-19. 
  • Anticoagulation use and Hemorrhagic Stroke in SARS-CoV-2 Patients Treated at a New York Healthcare System. 
  • Antidepressant use by race. 
  • Antihyperglycemic Medication Use Among Medicare Beneficiaries With Heart Failure, Diabetes Mellitus, and Chronic Kidney Disease. 
  • Antihypertensive medications and risk of death and hospitalizations in US hemodialysis patients: Evidence from a cohort study to inform hypertension treatment practices. 
  • Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial. 
  • Antithrombotic therapy with fondaparinux in relation to interventional management strategy in patients with ST- and non-ST-segment elevation acute coronary syndromes: an individual patient-level combined analysis of the Fifth and Sixth Organization to Assess Strategies in Ischemic Syndromes (OASIS 5 and 6) randomized trials. 
  • Antivenom Does Not Cause Snakebite Complications, Withholding It Does. 
  • Anxiety But Not Depression Predicts Poor Outcomes in Inflammatory Bowel Disease. 
  • Application of Diagnostic Algorithms for Heart Failure With Preserved Ejection Fraction to the Community. 
  • Approach to Abnormal Chest Computed Tomography Contrast Enhancement in the Hospitalized Patient. 
  • Appropriate Use of High-Flow Nasal Oxygen in Hospitalized Patients for Initial or Postextubation Management of Acute Respiratory Failure: A Clinical Guideline From the American College of Physicians. 
  • Appropriate use criteria: past, present, future. 
  • Are Hospice Admission Practices Associated With Hospice Enrollment for Older African Americans and Whites? 
  • Are Trends in Hospitalization Prior to Hospice Use Associated With Hospice Episode Characteristics? 
  • Are international differences in the outcomes of acute coronary syndromes apparent or real? A multilevel analysis. 
  • Are smoking and alcohol misuse associated with subsequent hospitalizations for ambulatory care sensitive conditions? 
  • Arrhythmic Burden and the Risk of Cardiovascular Outcomes in Patients With Paroxysmal Atrial Fibrillation and Cardiac Implanted Electronic Devices. 
  • Aspects of social support associated with depression at hospitalization and follow-up assessment among cardiac patients. 
  • Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia. 
  • Assessing Emotional Suffering in Palliative Care: Use of a Structured Note Template to Improve Documentation. 
  • Assessing diagnostic approaches to depression in medically ill older adults: how reliably can mental health professionals make judgments about the cause of symptoms? 
  • Assessing outcomes for consumers in New York's assisted outpatient treatment program. 
  • Assessing post-discharge costs of hepatopancreatic surgery: an evaluation of Medicare expenditure. 
  • Assessment and provision of rehabilitation among patients hospitalized with acute ischemic stroke in China: Findings from the China National Stroke Registry II. 
  • Assessment of Long-term Psychological Outcomes After Pediatric Intensive Care Unit Admission: A Systematic Review and Meta-analysis. 
  • Assessment of Trends in Guideline-Based Oral Anticoagulant Prescription for Patients With Ischemic Stroke and Atrial Fibrillation in China. 
  • Assisted early mobility for hospitalized older veterans: preliminary data from the STRIDE program. 
  • Association Between Atrial Fibrillation Symptoms, Quality of Life, and Patient Outcomes: Results From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). 
  • Association Between Hospital Process Composite Performance and Patient Outcomes After In-Hospital Cardiac Arrest Care. 
  • Association Between Hospital Volumes and Clinical Outcomes for Patients With Nontraumatic Subarachnoid Hemorrhage. 
  • Association Between Patient Satisfaction and Short-Term Outcomes After Major Cancer Surgery. 
  • Association Between Prompt Defibrillation and Epinephrine Treatment With Long-Term Survival After In-Hospital Cardiac Arrest. 
  • Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus: Secondary Analysis of a Randomized Clinical Trial. 
  • Association Between Symptom Burden and Time to Hospitalization, Nursing Home Placement, and Death Among the Chronically Ill Urban Homebound. 
  • Association between Dysphagia and Surgical Outcomes across the Continuum of Frailty. 
  • Association between Furosemide Exposure and Patent Ductus Arteriosus in Hospitalized Infants of Very Low Birth Weight. 
  • Association between Respiratory Failure and Clinical Outcomes in Patients with Acute Heart Failure: Analysis of 5 Pooled Clinical Trials. 
  • Association between area-level socioeconomic status, accessibility and diabetes-related hospitalisations: a cross-sectional analysis of data from Western Victoria, Australia. 
  • Association between beta-blocker use and mortality/morbidity in older patients with heart failure with reduced ejection fraction. A propensity score-matched analysis from the Swedish Heart Failure Registry. 
  • Association between body mass index and in-hospital outcomes: Analysis of the nationwide inpatient database. 
  • Association between diabetes mellitus and post-discharge outcomes in patients hospitalized with heart failure: findings from the EVEREST trial. 
  • Association between glycated haemoglobin levels and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: a secondary analysis of the TECOS randomized clinical trial. 
  • Association between patient beliefs and medication adherence following hospitalization for acute coronary syndrome. 
  • Association between performance measures and clinical outcomes for patients hospitalized with heart failure. 
  • Association between positive urine cultures and necrotizing enterocolitis in a large cohort of hospitalized infants. 
  • Association between resting heart rate, chronotropic index, and long-term outcomes in patients with heart failure receiving β-blocker therapy: data from the HF-ACTION trial. 
  • Association between socioeconomic status and risk of hospitalization due to child maltreatment in the USA. 
  • Association between stroke center hospitalization for acute ischemic stroke and mortality. 
  • Association between the 2012 Health and Social Care Act and specialist visits and hospitalisations in England: A controlled interrupted time series analysis. 
  • Association between the timing of surgery for complicated, left-sided infective endocarditis and survival. 
  • Association of Anemia with Venous Thromboembolism in Acutely Ill Hospitalized Patients: An APEX Trial Substudy. 
  • Association of Billed Advance Care Planning with End-of-Life Care Intensity for 2017 Medicare Decedents. 
  • Association of COVID-19 Infection With Survival After In-Hospital Cardiac Arrest Among US Adults. 
  • Association of Chronic Renal Insufficiency With In-Hospital Outcomes in Primary Atrial Fibrillation Hospitalizations. 
  • Association of Current Opioid Use With Serious Adverse Events Among Older Adult Survivors of Breast Cancer. 
  • Association of Early Aspirin Use With In-Hospital Mortality in Patients With Moderate COVID-19. 
  • Association of Get With The Guidelines-Stroke Program Participation and Clinical Outcomes for Medicare Beneficiaries With Ischemic Stroke. 
  • Association of Heart Failure With Outcomes Among Patients With Peripheral Artery Disease: Insights From EUCLID. 
  • Association of Hospital Performance Based on 30-Day Risk-Standardized Mortality Rate With Long-term Survival After Heart Failure Hospitalization: An Analysis of the Get With The Guidelines-Heart Failure Registry. 
  • Association of IL6ST (gp130) Polymorphism with Functional Outcome Following Spontaneous Intracerebral Hemorrhage. 
  • Association of Implantable Device Measured Physical Activity With Hospitalization for Heart Failure. 
  • Association of Kidney Disease Quality of Life (KDQOL-36) with mortality and hospitalization in older adults receiving hemodialysis. 
  • Association of Multimorbidity with Mortality and Healthcare Utilization in Chronic Kidney Disease. 
  • Association of Opioids and Nonsteroidal Anti-inflammatory Drugs With Outcomes in CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) Study. 
  • Association of Practice-Level Hospital Use With End-of-Life Outcomes, Readmission, and Weekend Hospitalization Among Medicare Beneficiaries With Cancer. 
  • Association of Preoperative Renin-Angiotensin System Inhibitors With Prevention of Postoperative Atrial Fibrillation and Adverse Events: A Systematic Review and Meta-analysis. 
  • Association of Sensory and Cognitive Impairment With Healthcare Utilization and Cost in Older Adults. 
  • Association of Smoking Status With Long-Term Mortality and Health Status After Transcatheter Aortic Valve Replacement: Insights From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. 
  • Association of Tricuspid Regurgitation With Transcatheter Aortic Valve Replacement Outcomes: A Report From The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. 
  • Association of Vision Loss With Hospital Use and Costs Among Older Adults. 
  • Association of Visit-to-Visit Variability in Kidney Function and Serum Electrolyte Indexes With Risk of Adverse Clinical Outcomes Among Patients With Heart Failure With Preserved Ejection Fraction. 
  • Association of acute myocardial infarction cardiac arrest patient volume and in-hospital mortality in the United States: Insights from the National Cardiovascular Data Registry Acute Coronary Treatment And Intervention Outcomes Network Registry. 
  • Association of an Electroencephalography-Based Risk Score With Seizure Probability in Hospitalized Patients. 
  • Association of body mass index and long-term outcomes in older patients with non-ST-segment-elevation myocardial infarction: results from the CRUSADE Registry. 
  • Association of depression and survival in patients with chronic heart failure over 12 Years. 
  • Association of global weather changes with acute coronary syndromes: gaining insights from clinical trials data. 
  • Association of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three clinical trials. 
  • Association of inpatient vs outpatient onset of ST-elevation myocardial infarction with treatment and clinical outcomes. 
  • Association of intradialytic blood pressure changes with hospitalization and mortality rates in prevalent ESRD patients. 
  • Association of obesity with cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: Insights from TECOS. 
  • Association of peripheral artery disease with treatment and outcomes in acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE). 
  • Association of prolonged QRS duration with death in a clinical trial of pacemaker therapy for sinus node dysfunction. 
  • Association of statin therapy with outcomes of acute coronary syndromes: the GRACE study. 
  • Association of the Affordable Care Act's Medicaid Expansion With Care Quality and Outcomes for Low-Income Patients Hospitalized With Heart Failure. 
  • Associations Between Blood Pressure and Outcomes Among Blacks in the Jackson Heart Study. 
  • Associations Between Unplanned Cardiac Reinterventions and Outcomes After Pediatric Cardiac Operations. 
  • Associations between published quality ratings of skilled nursing facilities and outcomes of medicare beneficiaries with heart failure. 
  • Associations between resources and practices of ILD centers and outcomes in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry. 
  • Associations between use of the hospitalist model and quality of care and outcomes of older patients hospitalized for heart failure. 
  • Associations between β-blocker therapy and cardiovascular outcomes in patients with diabetes and established cardiovascular disease. 
  • Atrial fibrillation among Medicare beneficiaries hospitalized with sepsis: incidence and risk factors. 
  • Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program. 
  • Atrial fibrillation is an independent risk factor for heart failure hospitalization in heart failure with preserved ejection fraction. 
  • Atrial fibrillation or flutter on initial electrocardiogram is associated with worse outcomes in patients admitted for worsening heart failure with reduced ejection fraction: findings from the EVEREST Trial. 
  • Automated detection of physiologic deterioration in hospitalized patients. 
  • Automated versus Manual Data Extraction of the Padua Prediction Score for Venous Thromboembolism Risk in Hospitalized Older Adults. 
  • Average Temperature, Diurnal Temperature Variation, and Stroke Hospitalizations. 
  • Azimilide reduces emergency department visits and hospitalizations in patients with an implantable cardioverter-defibrillator in a placebo-controlled clinical trial. 
  • B-type natriuretic peptide level and postdischarge thrombotic events in older patients hospitalized with heart failure: insights from the Acute Decompensated Heart Failure National Registry. 
  • Bacterial etiology of community-acquired pneumonia in immunocompetent hospitalized patients and appropriateness of empirical treatment recommendations: an international point-prevalence study. 
  • Bariatric surgeries in north Carolina, 1990 to 2001: a gender comparison. 
  • Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19. 
  • Barriers to mobility during hospitalization from the perspectives of older patients and their nurses and physicians. 
  • Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF). 
  • Benefits and safety of candesartan treatment in heart failure are independent of age: insights from the Candesartan in Heart failure--Assessment of Reduction in Mortality and morbidity programme. 
  • Beta-blocker use and outcomes among hospitalized heart failure patients. 
  • Beyond the First Wave: Consequences of COVID-19 on High-Risk Infants and Families. 
  • Biomarker Profiles of Acute Heart Failure Patients With a Mid-Range Ejection Fraction. 
  • Biomarkers of Mineral and Bone Metabolism and 20-Year Risk of Hospitalization With Infection: The Atherosclerosis Risk in Communities Study. 
  • Black Race Is Associated with a Lower Risk of Bronchopulmonary Dysplasia. 
  • Blood pressure and in-hospital outcomes in patients presenting with ischaemic stroke. 
  • Blood transfusions in gunshot-wound-related emergency department visits and hospitalizations in the United States. 
  • Bloodstream Infections and Frequency of Pretreatment Associated With Age and Hospitalization Status in Sub-Saharan Africa. 
  • Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes: Findings From the ASCEND-HF Trial. 
  • Breast cancer and estrogen replacement therapy. 
  • Bringing research directly to families in the era of COVID-19. 
  • Burden of Invasive Staphylococcus aureus Infections in Hospitalized Infants. 
  • Burden of Persistent Vomiting With Cannabis Use Disorder: Report From 55,549 Hospitalizations in the United States. 
  • Burden of early hospitalization after simultaneous liver-kidney transplantation: Results from the US Multicenter SLKT Consortium. 
  • Burden of influenza-related hospitalizations among children with sickle cell disease. 
  • CABG Improves Outcomes in Patients With Ischemic Cardiomyopathy: 10-Year Follow-Up of the STICH Trial. 
  • COVID-19-associated psychosis: A systematic review of case reports. 
  • Can caregivers report their care recipients' post-stroke hospitalizations and outpatient visits accurately? Findings of an Asian prospective stroke cohort. 
  • Candida albicans and non-albicans bloodstream infections in adult and pediatric patients: comparison of mortality and costs. 
  • Cannabis Use Disorder and Epilepsy: A Cross-National Analysis of 657 072 Hospitalized Patients. 
  • Cannabis Use Is an Independent Predictor for Acute Myocardial Infarction Related Hospitalization in Younger Population. 
  • Cannabis use disorder among atrial fibrillation admissions, 2008-2018. 
  • Cannabis use disorder and increased risk of arrhythmia-related hospitalization in young adults. 
  • Capitalizing on prescribing pattern variation to compare medications for type 2 diabetes. 
  • Cardiac Arrest and Cardiopulmonary Resuscitation Outcome Reports: Update of the Utstein Resuscitation Registry Template for In-Hospital Cardiac Arrest: A Consensus Report From a Task Force of the International Liaison Committee on Resuscitation (American Heart Association, European Resuscitation Council, Australian and New Zealand Council on Resuscitation, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Southern Africa, Resuscitation Council of Asia). 
  • Cardiac Rehabilitation After Ventricular Assist Device Implantation: A Worthwhile Exercise? 
  • Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure: results from the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) trial. 
  • Cardiometabolic Assessment, Diagnosis, and Treatment of Chronic Medical Illnesses During an Inpatient Psychiatric Hospitalization: Colocated Medical Care Versus Treatment as Usual. 
  • Cardiorenal interactions: insights from the ESCAPE trial. 
  • Cardiovascular Risk Factor Profiles, Emergency Department Visits, and Hospitalizations for Women and Men with a History of Stroke or Transient Ischemic Attack: A Cross-Sectional Study. 
  • Cardiovascular Risk Factors and Clinical Outcomes among Patients Hospitalized with COVID-19: Findings from the World Heart Federation COVID-19 Study. 
  • Cardiovascular Testing and Clinical Outcomes in Emergency Department Patients With Chest Pain. 
  • Cardioversion and subsequent quality of life and natural history of atrial fibrillation. 
  • Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure: Rationale and design of CONNECT-HF. 
  • Care and outcomes of Hispanic patients admitted with heart failure with preserved or reduced ejection fraction: findings from get with the guidelines-heart failure. 
  • Caregiver Health-Related Quality of Life, Burden, and Patient Outcomes in Ambulatory Advanced Heart Failure: A Report From REVIVAL. 
  • Cascade iatrogenesis: factors leading to the development of adverse events in hospitalized older adults. 
  • Case report of treatment of severe mood disorder in an inpatient setting: when less is more. 
  • Catechol-O-methyltransferase genotype predicts pain severity in hospitalized burn patients. 
  • Catheter Ablation of Atrial Fibrillation in U.S. Community Practice--Results From Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). 
  • Catheter ablation of atrial fibrillation with heart failure: An updated meta-analysis of randomized trials. 
  • Cefepime and Ceftazidime Safety in Hospitalized Infants. 
  • Ceftobiprole versus daptomycin in Staphylococcus aureus bacteremia: a novel protocol for a double-blind, Phase III trial. 
  • Central line-associated bloodstream infection in hospitalized children with peripherally inserted central venous catheters: extending risk analyses outside the intensive care unit. 
  • Changes in Dyspnea Status During Hospitalization and Postdischarge Health-Related Quality of Life in Patients Hospitalized for Heart Failure: Findings From the EVEREST Trial. 
  • Changes in childhood pneumonia and infant mortality rates following introduction of the 13-valent pneumococcal conjugate vaccine in Nicaragua. 
  • Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics. 
  • Changes in religious coping and relapse to drug use among opioid-dependent patients following inpatient detoxification. 
  • Changing gender prevalence of stone disease. 
  • Changing patterns of hospitalization for children requiring surgery. 
  • Changing preferences for survival after hospitalization with advanced heart failure. 
  • Characterising the long-term clinical outcomes of 1190 hospitalised patients with COVID-19 in New York City: a retrospective case series. 
  • Characteristics and Outcomes of COVID-19 in Patients on Left Ventricular Assist Device Support. 
  • Characteristics and Outcomes of Dementia Patients Who Receive Inpatient Palliative Care Consultation. 
  • Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction After a Recent Worsening Heart Failure Event. 
  • Characteristics and Outcomes of Suspected Digoxin Toxicity and Immune Fab Treatment Over the Past Two Decades-2000-2020. 
  • Characteristics and current practice of parenteral nutrition in hospitalized patients. 
  • Characteristics and in-hospital outcomes of patients presenting with non-ST-segment elevation myocardial infarction found to have significant coronary artery disease on coronary angiography and managed medically: stratification according to renal function. 
  • Characteristics and outcomes of adults with chronic obstructive pulmonary disease and atrial fibrillation. 
  • Characteristics of Acute Heart Failure Hospitalizations Based on Presenting Severity. 
  • Characteristics of Adult Rapid Response Events in a Freestanding Children's Hospital. 
  • Characteristics of nontraumatic subarachnoid hemorrhage in the United States in 2003. 
  • Characteristics of primary care and rates of pediatric hospitalizations in Brazil. 
  • Characteristics of schizophrenic and depressed patients excluded from clinical research. 
  • Characteristics, quality of care, and in-hospital outcomes of Asian-American heart failure patients: Findings from the American Heart Association Get With The Guidelines-Heart Failure Program. 
  • Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. 
  • Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial. 
  • Characterization of Mineralocorticoid Receptor Antagonist Therapy Initiation in High-Risk Patients With Heart Failure. 
  • Characterization of cardiovascular clinical events and impact of event adjudication on the treatment effect of darapladib versus placebo in patients with stable coronary heart disease: Insights from the STABILITY trial. 
  • Characterization of heart failure patients with preserved ejection fraction: a comparison between ADHERE-US registry and ADHERE-International registry. 
  • Characterization of hemodynamically stable acute heart failure patients requiring a critical care unit admission: Derivation, validation, and refinement of a risk score. 
  • Characterization of the Progression From Ambulatory to Hospitalized Heart Failure With Preserved Ejection Fraction. 
  • Characterizing major bleeding in patients with nonvalvular atrial fibrillation: a pharmacovigilance study of 27 467 patients taking rivaroxaban. 
  • Charges for Alcoholic Cirrhosis Exceed All Other Etiologies of Cirrhosis Combined: A National and State Inpatient Survey Analysis. 
  • Chest Radiographic Findings and Outcomes of Pneumonia Among Children in Botswana. 
  • Chikungunya and dengue fever among hospitalized febrile patients in northern Tanzania. 
  • Childhood Leukemia, Late Effects, and a Person-centric Model of Follow-up. 
  • Childhood cancer, endocrine disorders, and cohort studies. 
  • Childhood obesity in relation to poor asthma control and exacerbation: a meta-analysis. 
  • Children in the United States make close to 200,000 emergency department visits due to poisoning each year. 
  • Children's respiratory morbidity prevalence in relation to air pollution in four Chinese cities. 
  • Chronic pain in psychiatric [correction of psychotic] patients. 
  • Chronic vitamin K antagonist therapy and bleeding risk in ST elevation myocardial infarction patients. 
  • Cigarette smoking and acute non-influenzal respiratory disease in military cadets. 
  • Circulating long chain acylcarnitines and outcomes in diabetic heart failure: an HF-ACTION clinical trial substudy. 
  • Cisplatin versus carboplatin-based regimens for the treatment of patients with metastatic lung cancer. An analysis of Veterans Health Administration data. 
  • Clinical Effectiveness of Sacubitril/Valsartan Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction. 
  • Clinical Effectiveness of Statin Therapy After Ischemic Stroke: Primary Results From the Statin Therapeutic Area of the Patient-Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) Study. 
  • Clinical Epidemiology of Adults With Moderate Traumatic Brain Injury. 
  • Clinical Outcome and Utilization Profiles Among Latent Groups of High-Risk Patients: Moving from Segmentation Towards Intervention. 
  • Clinical Outcomes With Metformin and Sulfonylurea Therapies Among Patients With Heart Failure and Diabetes. 
  • Clinical Outcomes and Healthcare Utilization Related to Multidrug-Resistant Gram-Negative Infections in Community Hospitals. 
  • Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event: Insights From the VICTORIA Trial. 
  • Clinical Outcomes in Patients With Acute Decompensated Heart Failure Randomly Assigned to Sacubitril/Valsartan or Enalapril in the PIONEER-HF Trial. 
  • Clinical Outcomes of Older Kidney Transplant Recipients. 
  • Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convalescent Plasma. 
  • Clinical Prediction Models for Heart Failure Hospitalization in Type 2 Diabetes: A Systematic Review and Meta-Analysis. 
  • Clinical Significance of Early Fluid and Weight Change During Acute Heart Failure Hospitalization. 
  • Clinical and Echocardiographic Characteristics of Patients Hospitalized With Acute Versus Chronic Heart Failure With Preserved Ejection Fraction (From the ARIC Study). 
  • Clinical and financial outcomes due to methicillin resistant Staphylococcus aureus surgical site infection: a multi-center matched outcomes study. 
  • Clinical characteristics and 12-month outcomes of patients with valvular and non-valvular atrial fibrillation in Kenya. 
  • Clinical characteristics and long-term outcome of patients in whom congestive heart failure develops after thrombolytic therapy for acute myocardial infarction: development of a predictive model. 
  • Clinical characteristics and mortality after acute myocardial infarction-related hospitalization among Asians from a national population-based cohort study. 
  • Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices. 
  • Clinical characteristics and outcomes of hospitalized heart failure patients with systolic dysfunction and chronic obstructive pulmonary disease: findings from OPTIMIZE-HF. 
  • Clinical characteristics and outcomes of young and very young adults with heart failure: The CHARM programme (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity). 
  • Clinical characteristics of Kraepelinian schizophrenia: replication and extension of previous findings. 
  • Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program. 
  • Clinical course and outcome predictors of critically ill infants with complete DiGeorge anomaly following thymus transplantation. 
  • Clinical course of atrial fibrillation in older adults: the importance of cardiovascular events beyond stroke. 
  • Clinical determinants and prognostic significance of hypocapnia in acute heart failure. 
  • Clinical effectiveness of cardiac resynchronization therapy versus medical therapy alone among patients with heart failure: analysis of the ICD Registry and ADHERE. 
  • Clinical epidemiology and outcome of HIV-associated talaromycosis in Guangdong, China, during 2011-2017. 
  • Clinical evidence of early acute lung injury often precedes the diagnosis of ALI. 
  • Clinical factors related to morbidity and mortality in high-risk heart failure patients: the GUIDE-IT predictive model and risk score. 
  • Clinical field testing of an enhanced-activity intervention in hospitalized children with cancer. 
  • Clinical implications of chronic heart failure phenotypes defined by cluster analysis. 
  • Clinical outcome as a function of the PR-interval-there is virtue in moderation: data from the Duke Databank for cardiovascular disease. 
  • Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document. 
  • Clinical outcomes of fractional flow reserve by computed tomographic angiography-guided diagnostic strategies vs. usual care in patients with suspected coronary artery disease: the prospective longitudinal trial of FFR(CT): outcome and resource impacts study. 
  • Clinical profile and prognostic significance of natriuretic peptide trajectory following hospitalization for worsening chronic heart failure: findings from the ASTRONAUT trial. 
  • Clinical response and outcome of infection with Salmonella enterica serotype Typhi with decreased susceptibility to fluoroquinolones: a United States foodnet multicenter retrospective cohort study. 
  • Clinical trajectory of patients with a worsening heart failure event and reduced ventricular ejection fraction. 
  • Clinical trial testing in-home multidisciplinary care management for older adults with cognitive vulnerability: Rationale and study design. 
  • Clinical trials in hospitalized heart failure patients: targeting interventions to optimal phenotypic subpopulations. 
  • Clinical trials of pharmacological therapies in acute heart failure syndromes: lessons learned and directions forward. 
  • Clinical use of nefazodone in major depression: a 6-year perspective. 
  • Clinician Specialty, Access to Care, and Outcomes Among Patients with Peripheral Artery Disease. 
  • Clostridium difficile infection among kidney transplant recipients: frequency, clinical presentation, and outcome. 
  • Clustering of health, crime and social-welfare inequality in 4 million citizens from two nations. 
  • Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism. 
  • Code status transitions in patients with high-risk acute myeloid leukemia. 
  • Cognitive and somatic symptoms of depression are associated with medical comorbidity in patients after acute myocardial infarction. 
  • Cognitive function and acute care utilization. 
  • Cognitive functioning in late-life schizophrenia: a comparison of elderly schizophrenic patients and patients with Alzheimer's disease. 
  • Cognitive risk factors and suicide attempts among formerly hospitalized adolescents: a prospective naturalistic study. 
  • Combination decongestion therapy in hospitalized heart failure: loop diuretics, mineralocorticoid receptor antagonists and vasopressin antagonists. 
  • Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study. 
  • Combining adult with pediatric patient data to develop a clinical decision support tool intended for children: leveraging machine learning to model heterogeneity. 
  • Commentary: Preventable Hospitalization Rate as a Marker of Surgical Quality: Easy to Measure, Hard to Modify. 
  • Common Data Elements for Unruptured Intracranial Aneurysms and Aneurysmal Subarachnoid Hemorrhage: Recommendations from the Working Group on Hospital Course and Acute Therapies-Proposal of a Multidisciplinary Research Group. 
  • Common Medical Comorbidities Correlated With Poor Outcomes in Hip Periprosthetic Infection. 
  • Common and Costly Hospitalizations Among Insured Young Adults Since the Affordable Care Act. 
  • Comorbidity of late life depression: an opportunity for research on mechanisms and treatment. 
  • Comparative Assessment of Utilization and Hospital Outcomes of Veterans Receiving VA and Non-VA Outpatient Dialysis. 
  • Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease. 
  • Comparative Effectiveness of CRT-D Versus Defibrillator Alone in HF Patients With Moderate-to-Severe Chronic Kidney Disease. 
  • Comparative Effectiveness of Implantable Cardioverter Defibrillators for Primary Prevention in Women. 
  • Comparative analysis of length of stay, hospitalization costs, opioid use, and discharge status among spine surgery patients with postoperative pain management including intravenous versus oral acetaminophen. 
  • Comparative changes of pre-operative autologous transfusions and peri-operative cell salvage in the United States. 
  • Comparative diagnostic criteria for melancholia and endogenous depression. 
  • Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. 
  • Comparative safety profile of chloral hydrate versus other sedatives for procedural sedation in hospitalized infants. 
  • Comparing Medical Costs and Use After Laparoscopic Adjustable Gastric Banding and Roux-en-Y Gastric Bypass. 
  • Comparing mortality and time until death for medicare HMO and FFS beneficiaries. 
  • Comparing the Safety and Cost of Image-Guided Percutaneous Gastrostomy Tube Placement in the Outpatient Versus Overnight Observation Setting in a Single-Center Retrospective Study. 
  • Comparing three life-limiting diseases: does diagnosis matter or is sick, sick? 
  • Comparison of 2-Year Outcomes of Extended Criteria Cardiac Transplantation Versus Destination Left Ventricular Assist Device Therapy Using Continuous Flow. 
  • Comparison of Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction With Versus Without Hyperuricemia or Gout. 
  • Comparison of Clinical Characteristics and Outcomes of Patients With Versus Without Diabetes Mellitus and With Versus Without Angina Pectoris (from the Duke Databank for Cardiovascular Disease). 
  • Comparison of Frequency of Frailty and Severely Impaired Physical Function in Patients ≥60 Years Hospitalized With Acute Decompensated Heart Failure Versus Chronic Stable Heart Failure With Reduced and Preserved Left Ventricular Ejection Fraction. 
  • Comparison of New York Heart Association Class and Patient-Reported Outcomes for Heart Failure With Reduced Ejection Fraction. 
  • Comparison of Outcomes Following a Switch From a Brand to an Authorized Versus Independent Generic Drug. 
  • Comparison of Patient-Reported Care Satisfaction, Quality of Warfarin Therapy, and Outcomes of Atrial Fibrillation: Findings From the ORBIT - AF Registry. 
  • Comparison of clinical trial outcome patterns in patients following acute coronary syndromes and in patients with chronic stable atherosclerosis. 
  • Comparison of composite measure methodologies for rewarding quality of care: an analysis from the American Heart Association's Get With The Guidelines program. 
  • Comparison of hospital costing methods in an economic evaluation of a multinational clinical trial. 
  • Comparison of older depressed hospitalized patients with and without heart failure/pulmonary disease. 
  • Comparison of outcomes for veterans receiving dialysis care from VA and non-VA providers. 
  • Comparison of the Incidence of Major Bleeding With Rivaroxaban Use Among Nonvalvular Atrial Fibrillation Patients With Versus Without Diabetes Mellitus. 
  • Comparison of the epidemiology and cost of Haemophilus influenzae type b disease in five western countries. 
  • Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized patients with and without concomitant piperacillin-tazobactam. 
  • Comparison of visual assessment of coronary stenosis with independent quantitative coronary angiography: Findings from the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trial. 
  • Comparisons of hospitalization rates among younger atrial fibrillation patients receiving different antiarrhythmic drugs. 
  • Compliance with clinical pathways for inpatient care in Chinese public hospitals. 
  • Comprehensive Reform Urgently Needed in Hospital Shackling Policy for Incarcerated Patients in the United States. 
  • Comprehensive electrocardiogram-to-device time for primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: A report from the American Heart Association mission: Lifeline program. 
  • Confirming the Bidirectional Nature of the Association Between Severe Hypoglycemic and Cardiovascular Events in Type 2 Diabetes: Insights From EXSCEL. 
  • Connecting the pieces of the cardiovascular care puzzle in Canada. 
  • Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement: Variation in Practice and Outcomes. 
  • Consideration of ICD-9 code-derived disease-specific safety indicators in CKD. 
  • Contemporary Burden of Primary Versus Secondary Heart Failure Hospitalizations in the United States. 
  • Contemporary Demographic, Treatment, and Geographic Distribution Patterns for Disorders of Sex Development. 
  • Contemporary Management of Concomitant Cardiac Arrest and Cardiogenic Shock Complicating Myocardial Infarction. 
  • Contemporary Patterns of Early Coronary Angiography Use in Patients With Non-ST-Segment Elevation Myocardial Infarction in the United States: Insights From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry. 
  • Contemporary outpatient management of patients with worsening heart failure with reduced ejection fraction: Rationale and design of the CHART-HF study. 
  • Contemporary testing for enteric pathogens: the potential for cost, time, and health care savings. 
  • Contemporary trends and predictors of postacute service use and routine discharge home after stroke. 
  • Continuation versus discontinuation of ACE inhibitors or angiotensin II receptor blockers in COVID-19: effects on blood pressure control and mortality. 
  • Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial. 
  • Continuing medication and hospitalization outcomes after assisted outpatient treatment in New York. 
  • Contrasting methicillin-resistant Staphylococcus aureus colonization in Veterans Affairs and community nursing homes. 
  • Contribution of individual components to composite end points in contemporary cardiovascular randomized controlled trials. 
  • Coping responses in depressed, socially maladjusted, and suicidal adolescents. 
  • Coronary bypass surgery with or without surgical ventricular reconstruction. 
  • Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy. 
  • Coronary-artery bypass surgery in patients with left ventricular dysfunction. 
  • Coronavirus disease 2019 pregnancy outcomes in a racially and ethnically diverse population. 
  • Correction of anemia with epoetin alfa in chronic kidney disease. 
  • Corticosteroids and increased risk of readmission after acute chest syndrome in children with sickle cell disease. 
  • Cost effectiveness of inpatient initiation of antiarrhythmic therapy for supraventricular tachycardias. 
  • Cost minimization in endoscopy center scheduling: a case-controlled study. 
  • Cost of Inpatient Care of Patients With Pemphigus in the United States: Translating Dollars and Cents Into Improved Patient Care. 
  • Cost trajectories as a measure of functional resilience after hospitalization in older adults. 
  • Cost-effectiveness of Venous Thromboembolism Prophylaxis After Hospitalization in Patients With Inflammatory Bowel Disease. 
  • Cost-effectiveness of early palliative care intervention in recurrent platinum-resistant ovarian cancer. 
  • Cost-effectiveness of improving primary care treatment of late-life depression. 
  • Cost-effectiveness of revascularization strategies: the ASCERT study. 
  • Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia. 
  • Costs and outcomes of hip fracture and stroke, 1984 to 1994. 
  • Costs of periprocedural complications in patients treated with transcatheter aortic valve replacement: results from the Placement of Aortic Transcatheter Valve trial. 
  • Critical Care Resource Utilization and Outcomes of Children With Moderate Traumatic Brain Injury. 
  • Critical care admission following elective surgery was not associated with survival benefit: prospective analysis of data from 27 countries. 
  • Current trends and 30-day surgical outcomes for thyroglossal duct cyst excision in children. 
  • Dalbavancin Pharmacokinetics and Safety in Children 3 Months to 11 Years of Age. 
  • Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. 
  • Dapagliflozin in Patients Recently Hospitalized With Heart Failure and Mildly Reduced or Preserved Ejection Fraction. 
  • Days Alive and Out of Hospital: Exploring a Patient-Centered, Pragmatic Outcome in a Clinical Trial of Patients With Acute Coronary Syndromes. 
  • Days alive and out of hospital and the patient journey in patients with heart failure: Insights from the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program. 
  • Death and rehospitalization after transient ischemic attack or acute ischemic stroke: one-year outcomes from the adherence evaluation of acute ischemic stroke-longitudinal registry. 
  • Death or hospitalization of patients on chronic hemodialysis is associated with a physician-based diagnosis of depression. 
  • Decision analysis of hematopoietic growth factor use in patients receiving cancer chemotherapy. 
  • Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. 
  • Decreased Antibiotic Utilization After Sinus Surgery in Cystic Fibrosis Patients With Lung Transplantation. 
  • Decreasing tracheostomy placement in hospitalized pediatric patients with subglottic stenosis - Kids' Inpatient Database (KID) analysis. 
  • Defining a Hospital Volume Threshold for Minimally Invasive Pancreaticoduodenectomy in the United States. 
  • Delay from symptom onset to hospital presentation for patients with non-ST-segment elevation myocardial infarction. 
  • Delay to reperfusion in patients with acute myocardial infarction presenting to acute care hospitals: an international perspective. 
  • Delayed Admissions to the Pediatric Intensive Care Unit: Progression of Disease or Errors in Emergency Department Management. 
  • Demographic and diagnostic characteristics of inmates receiving mental health services in state adult correctional facilities: United States, 1988. 
  • Demographic, presentation, and treatment factors and racial disparities in ovarian cancer hospitalization outcomes. 
  • Demographics, Care Patterns, and Outcomes of Patients Admitted to Cardiac Intensive Care Units: The Critical Care Cardiology Trials Network Prospective North American Multicenter Registry of Cardiac Critical Illness. 
  • Demographics, clinical characteristics, and outcomes of patients hospitalized for decompensated heart failure: observations from the IMPACT-HF registry. 
  • Depression and Anxiety Disorders among Hospitalized Women with Breast Cancer. 
  • Depression and antidepressant use after stroke and transient ischemic attack. 
  • Depression and major outcomes in older patients with heart failure. 
  • Depression in elderly hospitalized patients with medical illness. 
  • Depression in medically ill hospitalized older adults: prevalence, characteristics, and course of symptoms according to six diagnostic schemes. 
  • Depressive disorders in older medical inpatients. 
  • Depressive disorders: treatment patterns and costs of treatment in the private sector of the United States. 
  • Depressive symptoms and nine-year survival of 1,001 male veterans hospitalized with medical illness. 
  • Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3). 
  • Design and rationale of the PROTECT study: a placebo-controlled randomized study of the selective A1 adenosine receptor antagonist rolofylline for patients hospitalized with acute decompensated heart failure and volume overload to assess treatment effect on congestion and renal function. 
  • Designing effective drug and device development programs for hospitalized heart failure: a proposal for pretrial registries. 
  • Detection of bloodstream pathogens in a bacille Calmette-Guérin (BCG)-vaccinated pediatric population in Malawi: a pilot study. 
  • Determinants of Diuretic Responsiveness and Associated Outcomes During Acute Heart Failure Hospitalization: An Analysis From the NHLBI Heart Failure Network Clinical Trials. 
  • Determination of hospitalization type by investigator case report form or adjudication committee in a large heart failure clinical trial (β-Blocker Evaluation of Survival Trial [BEST]). 
  • Developing a risk model for in-hospital adverse events following implantable cardioverter-defibrillator implantation: a report from the NCDR (National Cardiovascular Data Registry). 
  • Development and Performance of a Clinical Decision Support Tool to Inform Resource Utilization for Elective Operations. 
  • Development and Validation of Machine Learning Models to Predict Admission From Emergency Department to Inpatient and Intensive Care Units. 
  • Development and validation of a risk model for in-hospital worsening heart failure from the Acute Decompensated Heart Failure National Registry (ADHERE). 
  • Development of an Administrative Data-Based Frailty Index for Older Adults Receiving Dialysis. 
  • Development of heart and respiratory rate percentile curves for hospitalized children. 
  • Diabetes management and self-care education for hospitalized patients with cancer. 
  • Diabetes on a cardiovascular ward: adherence to current recommendations. 
  • Diabetes-related utilization and costs for inpatient and outpatient services in the Veterans Administration. 
  • Dialysis-requiring acute kidney injury among hospitalized adults with documented hepatitis C Virus infection: a nationwide inpatient sample analysis. 
  • Differences in admission rates and outcomes between men and women presenting to emergency departments with coronary syndromes. 
  • Differences in health care use and outcomes by the timing of in-hospital worsening heart failure. 
  • Differences in inducibility and prognosis of in-hospital versus out-of-hospital identified nonsustained ventricular tachycardia in patients with coronary artery disease: clinical and trial design implications. 
  • Differences in pain management between hematologists and hospitalists caring for patients with sickle cell disease hospitalized for vasoocclusive crisis. 
  • Differences in psychosocial and health correlates of major and minor depression in medically ill older adults. 
  • Differences in risk perception and quit rates among hospitalized veteran pipe smokers, cigarette smokers, and dual users. 
  • Differences in short-term versus long-term outcomes of older black versus white patients with myocardial infarction: findings from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of American College of Cardiology/American Heart Association Guidelines (CRUSADE). 
  • Direct and indirect costs for hospitalized patients with dengue in Southern Sri Lanka. 
  • Discharge information and support for veterans Receiving Outpatient Care in the Emergency Department: study design and methods. 
  • Discharge to a skilled nursing facility and subsequent clinical outcomes among older patients hospitalized for heart failure. 
  • Discordance of databases designed for claims payment versus clinical information systems. Implications for outcomes research. 
  • Discordances between predicted and actual risk in obese patients with suspected cardiac ischaemia. 
  • Discriminating clinical features of heart failure with preserved vs. reduced ejection fraction in the community. 
  • Disparities in hospitalization outcomes among African-American and White prostate cancer patients. 
  • Disparities in the Management of Newly Diagnosed Paroxysmal Supraventricular Tachycardia for Women Versus Men in the United States. 
  • Disproportionate Use of Inpatient Care by Older Adults With Kidney Stones. 
  • Disproportionate costs and charges for pediatric catheter ablation: supply and demand... or just supply? 
  • Distress in patients with acute leukemia: a concept analysis. 
  • Do children evaluated for maltreatment have higher subsequent emergency department and inpatient care utilization compared to a general pediatric sample? 
  • Do heart failure disease management programs make financial sense under a bundled payment system? 
  • Does PCMH "Work"?--The Need to Use Implementation Science to Make Sense of Conflicting Results. 
  • Does aspirin use adversely influence intermediate-term postdischarge outcomes for hospitalized patients who are treated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers? Findings from Organized Program to Facilitate Life-Saving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). 
  • Does influenza vaccination or RSV prophylaxis impact resource utilization for children after the diagnosis of airway disorders? 
  • Does intent matter? The medical and societal burden of self-inflicted injury. 
  • Does occupation explain gender and other differences in work-related eye injury hospitalization rates? 
  • Does the discharge ECG provide additional prognostic insight(s) in non-ST elevation ACS patients from that acquired on admission? 
  • Dose of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Outcomes in Heart Failure: A Meta-Analysis. 
  • Dosing of beta-blocker therapy before, during, and after hospitalization for heart failure (from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure). 
  • Dosing recommendations and prescribing patterns for depressed medically ill hospitalized older patients. 
  • Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). 
  • Dronedarone in high-risk permanent atrial fibrillation. 
  • Duration and complications of diabetes mellitus and the associated risk of infective endocarditis. 
  • Dyadic approach to post-stroke hospitalizations: role of caregiver and patient characteristics. 
  • Dyspnoea and worsening heart failure in patients with acute heart failure: results from the Pre-RELAX-AHF study. 
  • Dyspnoea in patients with acute heart failure: an analysis of its clinical course, determinants, and relationship to 60-day outcomes in the PROTECT pilot study. 
  • EAA supplementation to increase nitrogen intake improves muscle function during bed rest in the elderly. 
  • Early Adoption of Sacubitril/Valsartan for Patients With Heart Failure With Reduced Ejection Fraction: Insights From Get With the Guidelines-Heart Failure (GWTG-HF). 
  • Early Ambulation Among Hospitalized Heart Failure Patients Is Associated With Reduced Length of Stay and 30-Day Readmissions. 
  • Early and Long-term Outcomes of Older Adults after Acute Care Encounters for Chronic Obstructive Pulmonary Disease Exacerbation. 
  • Early diuretic strategies and the association with In-hospital and Post-discharge outcomes in acute heart failure. 
  • Early glycoprotein IIb/IIIa inhibitor use for non-ST-segment elevation acute coronary syndrome: patient selection and associated treatment patterns. 
  • Early intravenous heart failure therapy and outcomes among older patients hospitalized for acute decompensated heart failure: findings from the Acute Decompensated Heart Failure Registry Emergency Module (ADHERE-EM). 
  • Early reinfarction after fibrinolysis: experience from the global utilization of streptokinase and tissue plasminogen activator (alteplase) for occluded coronary arteries (GUSTO I) and global use of strategies to open occluded coronary arteries (GUSTO III) trials. 
  • Early versus late readmission during the vulnerable phase following hospitalization for heart failure: reply. 
  • Early vs. late worsening heart failure during acute heart failure hospitalization: insights from the PROTECT trial. 
  • Early withdrawal of statin therapy in patients with non-ST-segment elevation myocardial infarction: national registry of myocardial infarction. 
  • Early, Goal-Directed Therapy for Septic Shock - A Patient-Level Meta-Analysis. 
  • Economic analysis of a tailored behavioral intervention to improve blood pressure control for primary care patients. 
  • Economic analysis of prophylactic pegfilgrastim in adult cancer patients receiving chemotherapy. 
  • Economic burden in US patients with newly diagnosed acute myeloid leukemia receiving intensive induction chemotherapy. 
  • Economic burden of congenital athymia in the United States for patients receiving supportive care during the first 3 years of life. 
  • Economic effects of beta-blocker therapy in patients with heart failure. 
  • Economic evaluation of the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) randomized controlled trial: an exercise training study of patients with chronic heart failure. 
  • Economic evaluation of the benefits of reducing acute cardiorespiratory morbidity associated with air pollution. 
  • Economic evaluation of weekly epoetin alfa versus biweekly darbepoetin alfa for chemotherapy-induced anaemia: evidence from a 16-week randomised trial. 
  • Economic evaluation of zoledronic acid versus pamidronate for the prevention of skeletal-related events in metastatic breast cancer and multiple myeloma. 
  • Economic impact of new interventional therapies: are we asking the right questions? 
  • Economic implications of the prophylactic use of intraaortic balloon counterpulsation in the setting of acute myocardial infarction. The Randomized IABP Study Group. Intraaortic Balloon Pump. 
  • Economics of treating heart failure. 
  • Educational videos to reduce racial disparities in ICD therapy via innovative designs (VIVID): a randomized clinical trial. 
  • Effect of Antimicrobial Therapy on Respiratory Hospitalization or Death in Adults With Idiopathic Pulmonary Fibrosis: The CleanUP-IPF Randomized Clinical Trial. 
  • Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF]). 
  • Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis. 
  • Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial. 
  • Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical Trial. 
  • Effect of Endobronchial Coils vs Usual Care on Exercise Tolerance in Patients With Severe Emphysema: The RENEW Randomized Clinical Trial. 
  • Effect of Free Dental Services on Individuals with Sickle Cell Disease. 
  • Effect of Haemophilus influenzae Type b and 13-Valent Pneumococcal Conjugate Vaccines on Childhood Pneumonia Hospitalizations and Deaths in Botswana. 
  • Effect of High-Deductible Insurance on High-Acuity Outcomes in Diabetes: A Natural Experiment for Translation in Diabetes (NEXT-D) Study. 
  • Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical Trial. 
  • Effect of Inpatient Palliative Care During Hematopoietic Stem-Cell Transplant on Psychological Distress 6 Months After Transplant: Results of a Randomized Clinical Trial. 
  • Effect of Inpatient Palliative Care on Quality of Life 2 Weeks After Hematopoietic Stem Cell Transplantation: A Randomized Clinical Trial. 
  • Effect of Intensive Blood Pressure Treatment on Heart Failure Events in the Systolic Blood Pressure Reduction Intervention Trial. 
  • Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial. 
  • Effect of Natriuretic Peptide-Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial. 
  • Effect of Real-time Patient-Centered Education Bundle on Administration of Venous Thromboembolism Prevention in Hospitalized Patients. 
  • Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation: A Randomized Clinical Trial. 
  • Effect of Regional Hospital Market Competition on Use Patterns of Free Flap Breast Reconstruction. 
  • Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes. 
  • Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI. 
  • Effect of Sotagliflozin on Total Hospitalizations in Patients With Type 2 Diabetes and Worsening Heart Failure : A Randomized Trial. 
  • Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure: The TRANSFORM-HF Randomized Clinical Trial. 
  • Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The VITALITY-HFpEF Randomized Clinical Trial. 
  • Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction: The SOCRATES-REDUCED Randomized Trial. 
  • Effect of a Hospital and Postdischarge Quality Improvement Intervention on Clinical Outcomes and Quality of Care for Patients With Heart Failure With Reduced Ejection Fraction: The CONNECT-HF Randomized Clinical Trial. 
  • Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya. 
  • Effect of a geriatric consultation team on functional status of elderly hospitalized patients. A randomized, controlled clinical trial. 
  • Effect of a pregroup collective project on the cohesiveness of inpatient therapy groups. 
  • Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: rationale and design of the ODYSSEY outcomes trial. 
  • Effect of aliskiren on post-discharge outcomes among diabetic and non-diabetic patients hospitalized for heart failure: insights from the ASTRONAUT trial. 
  • Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial. 
  • Effect of bucindolol on heart failure outcomes and heart rate response in patients with reduced ejection fraction heart failure and atrial fibrillation. 
  • Effect of cancer screening and desirable health behaviors on functional status, self-rated health, health service use and mortality. 
  • Effect of daily charge feedback on inpatient charges and physician knowledge and behavior. 
  • Effect of defibrillation threshold testing on heart failure hospitalization or death in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). 
  • Effect of disodium EDTA chelation regimen on cardiovascular events in patients with previous myocardial infarction: the TACT randomized trial. 
  • Effect of extended-duration thromboprophylaxis on venous thromboembolism and major bleeding among acutely ill hospitalized medical patients: a bivariate analysis. 
  • Effect of facility on the operative costs of distal radius fractures. 
  • Effect of insurance and racial disparities on outcomes in traumatic brain injury. 
  • Effect of insurance status on postacute care among working age stroke survivors. 
  • Effect of intravenous iron use on hospitalizations in patients undergoing hemodialysis: a comparative effectiveness analysis from the DEcIDE-ESRD study. 
  • Effect of once-weekly exenatide on hospitalization for acute coronary syndrome or coronary revascularization in patients with type 2 diabetes mellitus. 
  • Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trial. 
  • Effect of primary prophylactic granulocyte-colony stimulating factor use on incidence of neutropenia hospitalizations for elderly early-stage breast cancer patients receiving chemotherapy. 
  • Effect of prior clopidogrel use on outcomes in medically managed acute coronary syndrome patients. 
  • Effect of prior stroke on the use of evidence-based therapies and in-hospital outcomes in patients with myocardial infarction (from the NCDR ACTION GWTG registry). 
  • Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes. 
  • Effect of sodium-glucose cotransporter 2 inhibitors on cardiovascular and kidney outcomes-Systematic review and meta-analysis of randomized placebo-controlled trials. 
  • Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial. 
  • Effectiveness of Granulocyte Colony-Stimulating Factor in Hospitalized Infants with Neutropenia. 
  • Effectiveness of a postoperative disposition protocol for sleep apnea surgery. 
  • Effectiveness of implantable cardioverter-defibrillators in survivors of inhospital cardiac arrest. 
  • Effectiveness of mRNA COVID-19 Vaccine Boosters Against Infection, Hospitalization, and Death: A Target Trial Emulation in the Omicron (B.1.1.529) Variant Era. 
  • Effectiveness of paliperidone palmitate vs haloperidol decanoate for maintenance treatment of schizophrenia: a randomized clinical trial. 
  • Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial. 
  • Effects of Liraglutide on Worsening Renal Function Among Patients With Heart Failure With Reduced Ejection Fraction: Insights From the FIGHT Trial. 
  • Effects of Serelaxin in Patients with Acute Heart Failure. 
  • Effects of Structured Exercise Interventions for Older Adults Hospitalized With Acute Medical Illness: A Systematic Review. 
  • Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study. 
  • Effects of a 9-Week Hybrid Comprehensive Telerehabilitation Program on Long-term Outcomes in Patients With Heart Failure: The Telerehabilitation in Heart Failure Patients (TELEREH-HF) Randomized Clinical Trial. 
  • Effects of a structured heart failure program on quality of life and frequency of hospital admission in Saudi Arabia. 
  • Effects of brief pain education on hospitalized cancer patients with moderate to severe pain. 
  • Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. 
  • Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial. 
  • Effects of enalapril in systolic heart failure patients with and without chronic kidney disease: insights from the SOLVD Treatment trial. 
  • Effects of involuntary outpatient commitment and depot antipsychotics on treatment adherence in persons with severe mental illness. 
  • Effects of serelaxin in subgroups of patients with acute heart failure: results from RELAX-AHF. 
  • Effects of sodium-glucose cotransporter 1 and 2 inhibitors on cardiovascular and kidney outcomes in type 2 diabetes: A meta-analysis update. 
  • Effects of the adenosine A1 receptor antagonist rolofylline on renal function in patients with acute heart failure and renal dysfunction: results from PROTECT (Placebo-Controlled Randomized Study of the Selective Adenosine A1 Receptor Antagonist Rolofylline for Patients Hospitalized with Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function). 
  • Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial. 
  • Efficacy and Safety of Sacubitril/Valsartan in High-Risk Patients in the PIONEER-HF Trial. 
  • Efficacy and Safety of Spironolactone in Acute Heart Failure: The ATHENA-HF Randomized Clinical Trial. 
  • Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. 
  • Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trial. 
  • Efficacy and safety of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute heart failure, with and without type 2 diabetes: a systematic review and meta-analysis. 
  • Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. 
  • Efficacy of tumour necrosis factor antagonists on remission, colectomy and hospitalisations in ulcerative colitis: Meta-analysis of placebo-controlled trials. 
  • Elaboration on premorbid intellectual performance in schizophrenia: premorbid intellectual decline and risk for schizophrenia. 
  • Elderly women have lower rates of stroke, cardiovascular events, and mortality after hospitalization for transient ischemic attack. 
  • Electroconvulsive Treatment Utilization for the Inpatient Management of Severe Manic Episodes of Bipolar Disorder. 
  • Electronic Health Record Integration of Predictive Analytics to Select High-Risk Stable Patients With Non-ST-Segment-Elevation Myocardial Infarction for Intensive Care Unit Admission. 
  • Electronic health record risk score provides earlier prognostication of clinical outcomes in patients admitted to the cardiac intensive care unit. 
  • Electronic symptom monitoring in pediatric patients hospitalized for chemotherapy. 
  • Emergency Department (ED), ED Observation, Day Hospital, and Hospital Admissions for Adults with Sickle Cell Disease. 
  • Emergency Department Sickle Cell Assessment of Needs and Strengths (ED-SCANS), a focus group and decision support tool development project. 
  • Emergency Department Visits Versus Hospital Readmissions Among Patients Hospitalized for Heart Failure. 
  • Emergency Department and Hospital Use Among Adolescents With Justice System Involvement. 
  • Emergency department use and subsequent hospitalizations among members of a high-deductible health plan. 
  • Emergency department utilisation and critical readmission in patients with Fontan circulation. 
  • Emergency department visits and hospitalizations among patients with sickle cell disease in illinois, 2016-2020. 
  • Emergency room management of conversion disorders. 
  • End-of-life Heart Failure Care in the United States. 
  • Endemic cholera in rural Bangladesh, 1966-1980. 
  • Endoscopic management and outcomes of pregnant women hospitalized for nonvariceal upper GI bleeding: a nationwide analysis. 
  • Enhancing case ascertainment of Parkinson's disease using Medicare claims data in a population-based cohort: the Cardiovascular Health Study. 
  • Enoxaparin dosing and associated risk of in-hospital bleeding and death in patients with non ST-segment elevation acute coronary syndromes. 
  • Enrollment of Older Patients, Women, and Racial and Ethnic Minorities in Contemporary Heart Failure Clinical Trials: A Systematic Review. 
  • Epidemiology and Outcomes of Patients Readmitted to the Intensive Care Unit After Cardiac Intensive Care Unit Admission. 
  • Epidemiology of Staphylococcus aureus infections in patients admitted to freestanding pediatric hospitals, 2009-2016. 
  • Epidemiology of bloodstream infections in a bacille Calmette-Guérin-vaccinated pediatric population in Malawi. 
  • Epidemiology of hospital-based emergency department visits due to sports injuries. 
  • Epidemiology, Comorbidities, and Outcomes of Posterior Reversible Encephalopathy Syndrome in Children in the United States. 
  • Equilibration of hemoglobin concentration after transfusion in medical inpatients not actively bleeding. 
  • Equity of access to outpatient care and hospitalization among older community residents in Brazil. 
  • Establishing a pragmatic framework to optimise health outcomes in heart failure and multimorbidity (ARISE-HF): A multidisciplinary position statement. 
  • Estimating the Effectiveness of Rotavirus Vaccine Schedules. 
  • Estimation of Acutely Ill Medical Patients at Venous Thromboembolism Risk Eligible for Extended Thromboprophylaxis Using APEX Criteria in US Hospitals. 
  • Ethnic differences in the place of death of elderly hospice enrollees. 
  • Ethnic differences in use of inpatient mental health services by blacks, whites, and Hispanics in a national insured population. 
  • Etiology of severe non-malaria febrile illness in Northern Tanzania: a prospective cohort study. 
  • Evaluating the Effectiveness of Community and Hospital Medical Record Integration on Management of Behavioral Health in the Emergency Department. 
  • Evaluating the predictive validity of suicidal intent and medical lethality in youth. 
  • Evaluation of Nissen fundoplication in neurologically impaired children. 
  • Evaluation of disease-state management of dialysis patients. 
  • Evaluation of the Financial and Health Burden of Infants at Risk for Respiratory Syncytial Virus. 
  • Evaluation of the Incremental Prognostic Utility of Increasingly Complex Testing in Chronic Heart Failure. 
  • Evaluation of the WHO 2009 classification for diagnosis of acute dengue in a large cohort of adults and children in Sri Lanka during a dengue-1 epidemic. 
  • Evaluation of the effect of the modified early warning system on the nurse-led activation of the rapid response system. 
  • Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. 
  • Evidence-based therapies and mortality in patients hospitalized in December with acute myocardial infarction. 
  • Examination of baseline risk factors for QTc interval prolongation in patients prescribed intravenous haloperidol. 
  • Examining the relationship between adjunctive psychotherapy use and antipsychotic persistence and hospitalization. 
  • Executive function deficits in acute stroke. 
  • Expanded algorithm for managing patients with acute decompensated heart failure. 
  • Experiential Sampling in the Study of Multiple Personality Disorder 
  • Expert physician recommendations and current practice patterns for evaluating and treating men with osteoporotic hip fracture. 
  • Exposure to low-dose ambient fine particulate matter PM2.5 and Alzheimer's disease, non-Alzheimer's dementia, and Parkinson's disease in North Carolina. 
  • Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients. 
  • Extended duration of thromboprophylaxis for medically ill patients: a systematic review and meta-analysis of randomised controlled trials. 
  • Extent of ST-segment depression and cardiac events in non-ST-segment elevation acute coronary syndromes. 
  • Extent of, and factors associated with, delay to hospital presentation in patients with acute coronary disease (the GRACE registry). 
  • Factors Associated With Early Deaths Following Neonatal Male Circumcision in the United States, 2001 to 2010. 
  • Factors Associated With Head and Neck Cancer Hospitalization Cost and Length of Stay-A National Study. 
  • Factors Influencing Hospitalization Rates and Inpatient Cost of Patients with Tuberculosis in Jiangsu Province, China: An Uncontrolled before and after Study. 
  • Factors affecting prolonged length of stay in psychiatric patients in Japan: A retrospective observational study. 
  • Factors associated with failure of noninvasive positive pressure ventilation in the emergency department. 
  • Factors associated with persistently high-cost health care utilization for musculoskeletal pain. 
  • Factors associated with red blood cell, platelet, and plasma transfusions among inpatient hospitalizations: a nationally representative study in the United States. 
  • Factors associated with treatment delays in pediatric refractory convulsive status epilepticus. 
  • Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF. 
  • Familial schizophrenia and treatment response. 
  • Family caregiver satisfaction with inpatient rehabilitation care. 
  • Fatigue in Children With Sickle Cell Disease: Association With Neurocognitive and Social-Emotional Functioning and Quality of Life. 
  • Feasibility and applicability of paramedic-based prehospital fibrinolysis in a large North American center. 
  • Feasibility of Post-hospitalization Telemedicine Video Visits for Children With Medical Complexity. 
  • Fibroblast Growth Factor 23 and Risk of Hospitalization with Infection in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort (CRIC) Study. 
  • Fibroblast growth factor-23 and cardiovascular events in CKD. 
  • Firearm related injuries amongst children: estimates from the nationwide emergency department sample. 
  • First Identification and Description of Rickettsioses and Q Fever as Causes of Acute Febrile Illness in Nicaragua. 
  • First steps in analysing NHS waiting times: avoiding the 'stationary and closed population' fallacy. 
  • Fluoroquinolone prophylaxis reduces febrile neutropenia, bloodstream infections from mucosal translocations, and intensive care admissions in high risk hematological patients, a single center experience. 
  • Focused cardiac ultrasound as a predictor of readmission in acute decompensated heart failure. 
  • Follow-up of methadone maintenance patients hospitalized for abuse of alcohol and barbiturates. 
  • Fracture Reduction Affects Medicare Economics (FRAME): impact of increased osteoporosis diagnosis and treatment. 
  • Frailty Among Older Decompensated Heart Failure Patients: Prevalence, Association With Patient-Centered Outcomes, and Efficient Detection Methods. 
  • Frailty Assessment in Hospitalized Older Adults Using the Electronic Health Record. 
  • Frailty Status Modifies the Efficacy of Exercise Training Among Patients With Chronic Heart Failure and Reduced Ejection Fraction: An Analysis From the HF-ACTION Trial. 
  • Frailty and Clinical Outcomes in Chronic Obstructive Pulmonary Disease. 
  • Frailty and length of stay in older adults with blunt injury in a national multicentre prospective cohort study. 
  • Frailty as an instrument for evaluation of elderly patients with non-ST-segment elevation myocardial infarction: A follow-up after more than 5 years. 
  • Frailty predicts some but not all adverse outcomes in older adults discharged from the emergency department. 
  • Frequency and duration of hospitalization of patients with AD based on Medicare data: CERAD XX. 
  • Frequency of low serum high-density lipoprotein cholesterol levels in hospitalized patients with "desirable" total cholesterol levels. 
  • Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. 
  • Frequency, significance, and cost of recurrent ischemia after thrombolytic therapy for acute myocardial infarction. TAMI Study Group. 
  • From Hospital to Home: Impact of Transitional Care on Cost, Hospitalisation and Mortality. 
  • From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE). 
  • Ganciclovir/acyclovir prophylaxis reduces the incidence of cytomegalovirus infections in pancreas transplant recipients. 
  • Generalists and oncologists show similar care practices and outcomes for hospitalized late-stage cancer patients. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks for Treatment. 
  • Generalizability and longitudinal outcomes of a national heart failure clinical registry: Comparison of Acute Decompensated Heart Failure National Registry (ADHERE) and non-ADHERE Medicare beneficiaries. 
  • Genetic variants are not associated with outcome in patients with coronary artery disease and left ventricular dysfunction: results of the Genetic Substudy of the Surgical Treatment for Ischemic Heart Failure (STICH) trials. 
  • Geographic Differences in Patients in a Global Acute Heart Failure Clinical Trial (from the ASCEND-HF Trial). 
  • Geolocation of hospitalizations registered on the Brazilian National Health System's Hospital Information System: a solution based on the R Statistical Software. 
  • Geospatial Variations and Neighborhood Deprivation in Drug-Related Admissions and Overdoses. 
  • Geriatric Assessment as a Predictor of Tolerance, Quality of Life, and Outcomes in Older Patients With Head and Neck Cancers and Lung Cancers Receiving Radiation Therapy. 
  • Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation. 
  • Global Longitudinal Strain to Predict Respiratory Failure and Death in Patients Admitted for COVID-19-Related Disease. 
  • Global Respiratory Syncytial Virus-Related Infant Community Deaths. 
  • Global perspectives in hospitalized heart failure: regional and ethnic variation in patient characteristics, management, and outcomes. 
  • Global variation in clinical profile, management, and post-discharge outcomes among patients hospitalized for worsening chronic heart failure: findings from the ASTRONAUT trial. 
  • Global variation in quality of care among patients hospitalized with acute heart failure in an international trial: findings from the acute study clinical effectiveness of nesiritide in decompensated heart failure trial (ASCEND-HF). 
  • Glucose control in hospitalized patients. 
  • Glycated Hemoglobin and Outcomes of Heart Failure (from Get With the Guidelines-Heart Failure). 
  • Gram-negative bacteremia upon hospital admission: when should Pseudomonas aeruginosa be suspected? 
  • Granulocyte-colony stimulating factor use and medical costs after initial adjuvant chemotherapy in older patients with early-stage breast cancer. 
  • Greater Pain Severity Is Associated with Worse Outcomes in Patients with Heart Failure. 
  • Growth differentiation factor 15 (GDF-15) in patients admitted for acute heart failure: results from the RELAX-AHF study. 
  • Guidance for Structuring a Pediatric Intermediate Care Unit. 
  • Guideline-Directed Medical Therapy and Survival Following Hospitalization in Patients with Heart Failure. 
  • Guidelines of the National Comprehensive Cancer Network on the use of myeloid growth factors with cancer chemotherapy: a review of the evidence. 
  • Gun-Related and Other Violent Crime After Involuntary Commitment and Short-Term Emergency Holds. 
  • HIV risk behavior in opioid dependent adults seeking detoxification treatment: an exploratory comparison of heroin and oxycodone users. 
  • HIV-associated morbidity, mortality and diagnostic testing opportunities among inpatients at a referral hospital in northern Tanzania. 
  • HMO coverage reduces variations in the use of health care among patients under age sixty-five. 
  • Haemoconcentration during treatment of acute heart failure with cardiorenal syndrome: from the CARRESS-HF trial. 
  • Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial. 
  • Haemophilus influenzae type b infections in Victoria, Australia, 1985 to 1987. 
  • Has the frequency of bleeding changed over time for patients presenting with an acute coronary syndrome? The global registry of acute coronary events. 
  • Hazardous drinking and clinical correlates among suicidal patients receiving psychiatric inpatient care at military medical settings. 
  • Health Care Utilization Trends Across the Transition Period in a National Cohort of Adolescents and Young Adults With Type 1 Diabetes. 
  • Health care use and costs associated with use of a health club membership benefit in older adults with diabetes. 
  • Health care utilization before and after an outpatient ED visit in older people. 
  • Health care utilization following a homeless medical respite pilot program. 
  • Health care utilization of carpenters with substance abuse-related diagnoses. 
  • Health care utilization of families of carpenters with alcohol or substance abuse-related diagnoses. 
  • Health literacy interventions and outcomes: an updated systematic review. 
  • Health services utilization after induced abortions in Ontario: a comparison between community clinics and hospitals. 
  • Health-related quality of life 1-3 years post-myocardial infarction: its impact on prognosis. 
  • Health-related quality of life in older depressed psychogeriatric patients: one year follow-up. 
  • Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study. 
  • Healthcare access and utilization by patients infected with human immunodeficiency virus: does gender matter? 
  • Healthcare associated diarrhea, not Clostridioides difficile. 
  • Healthcare utilization and cost trajectories post-stroke: role of caregiver and stroke factors. 
  • Healthcare utilization and costs associated with dabigatran compared to warfarin treatment in newly diagnosed patients with non-valvular atrial fibrillation. 
  • Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association. 
  • Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes. 
  • Heart Transplantation After HeartMate 3 Use Shortens Hospitalization but Might Impose Increased Risk of Rejection. 
  • Heart failure complicating non-ST-segment elevation acute coronary syndrome: timing, predictors, and clinical outcomes. 
  • Heart failure disease management program experience in 4,545 heart failure admissions to a community hospital. 
  • Heart failure hospitalization is more common in pacemaker patients with sinus node dysfunction and a prolonged paced QRS duration. 
  • Heart failure medications prescribed at discharge for patients with left ventricular assist devices. 
  • Heart failure preserved ejection fraction (HFpEF): an integrated and strategic review. 
  • Heart failure quality of care and in-hospital outcomes during the COVID-19 pandemic: findings from the Get With The Guidelines-Heart Failure registry. 
  • Heart Failure Hospitalization and Guideline-Directed Prescribing Patterns Among Heart Failure With Reduced Ejection Fraction Patients. 
  • Heart Failure Outcomes and Associated Factors Among Veterans With Human Immunodeficiency Virus Infection. 
  • Heatwaves, medications, and heat-related hospitalization in older Medicare beneficiaries with chronic conditions. 
  • Hemodynamic findings in 123 patients with acute myocardial infarction on admission. 
  • Heparin-dependent platelet factor 4 antibodies and the impact of renal function on clinical outcomes: a retrospective study in hospitalized patients. 
  • Heterogeneous Outcomes of Heart Failure with Better Ejection Fraction. 
  • High prevalence of lack of knowledge of symptoms of acute myocardial infarction in Pakistan and its contribution to delayed presentation to the hospital. 
  • High-Sensitivity Troponin I in Hospitalized and Ambulatory Patients With Heart Failure With Preserved Ejection Fraction: Insights From the Heart Failure Clinical Research Network. 
  • High-deductible insurance: two-year emergency department and hospital use. 
  • High-dose influenza vaccine to reduce clinical outcomes in high-risk cardiovascular patients: Rationale and design of the INVESTED trial. 
  • Higher levels of CSF homovanillic acid in recently abstinent cocaine-dependent patients. 
  • Highest Obesity Category Associated With Largest Decrease in N-Terminal Pro-B-Type Natriuretic Peptide in Patients Hospitalized With Heart Failure With Preserved Ejection Fraction. 
  • Hip and other osteoporotic fractures increase the risk of subsequent fractures in nursing home residents. 
  • Histoplasmosis among hospitalized febrile patients in northern Tanzania. 
  • History of AIDS in HIV-Infected Patients Is Associated With Higher In-Hospital Mortality Following Admission for Acute Myocardial Infarction and Stroke. 
  • Home Health Care Use and Post-Discharge Outcomes After Heart Failure Hospitalizations. 
  • Home-Time After Discharge Among Patients Hospitalized With Heart Failure. 
  • Hospice policy and patterns of care. 
  • Hospital Emergency Treatment of Convulsive Status Epilepticus: Comparison of Pathways From Ten Pediatric Research Centers. 
  • Hospital Resource Utilization Before and After Transcatheter Aortic Valve Replacement: The STS/ACC TVT Registry. 
  • Hospital admissions for hyperglycemic emergencies in young adults at an inner-city hospital. 
  • Hospital and ED charges for spina bifida care in the United States between 2006 and 2014: Over $2 billion annually. 
  • Hospital experiences of young adults with congenital heart disease: divergence in expectations and dissonance in care. 
  • Hospital length of stay in patients with non-ST-segment elevation myocardial infarction. 
  • Hospital management of tuberculosis in a region with a low incidence of tuberculosis and a high prevalence of nontuberculous mycobacteria. 
  • Hospital readmissions following HLA-incompatible live donor kidney transplantation: A multi-center study. 
  • Hospital use and costs among patients with nonischemic cardiomyopathy in the first prospective randomized amlodipine survival evaluation study. 
  • Hospital variation in treatment and outcomes in acute coronary syndromes: Insights from the Alberta Contemporary Acute Coronary Syndrome Patients Invasive Treatment Strategies (COAPT) study. 
  • Hospital versus random digit dialing controls in the elderly. Observations from two case-control studies. 
  • Hospital-Acquired Pressure Injury Development Among Surgical Critical Care Patients Admitted With Community-Acquired Pressure Injury: A Retrospective Cohort Study. 
  • Hospital-Based Emergency Department Visits With Pediatric Burns: Characteristics and Outcomes. 
  • Hospital-Based Resource Use and Costs Among Patients With Idiopathic Pulmonary Fibrosis Enrolled in the Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry. 
  • Hospital-acquired Pneumonia and Ventilator-associated Pneumonia in Children: A Prospective Natural History and Case-Control Study. 
  • Hospital-acquired complications in a randomized controlled clinical trial of a geriatric consultation team. 
  • Hospital-associated deconditioning and dysfunction. 
  • Hospital-associated venous thromboembolism in children: incidence and clinical characteristics. 
  • Hospital-based emergency department visits in children with motor vehicle traffic accidents: estimates from the nationwide emergency department sample. 
  • Hospital-based quality improvement interventions for patients with heart failure: a systematic review. 
  • Hospital-level variation in mortality and rehospitalization for medicare beneficiaries with acute ischemic stroke. 
  • Hospitalisation among the elderly in urban China. 
  • Hospitalization Among Patients With Atrial Fibrillation and a Recent Acute Coronary Syndrome or Percutaneous Coronary Intervention Treated With Apixaban or Aspirin: Insights From the AUGUSTUS Trial. 
  • Hospitalization Patterns and Impact of a Magnetically-Levitated Left Ventricular Assist Device in the MOMENTUM 3 Trial. 
  • Hospitalization Risk Among Older Adults with Sensory Impairments: Development of a Prognostic Model. 
  • Hospitalization after Cataract Surgery in a Nationwide Managed-Care Population. 
  • Hospitalization and case-fatality rates for stroke in Canada from 1982 through 1991. The Canadian Collaborative Study Group of Stroke Hospitalizations. 
  • Hospitalization and case-fatality rates for subarachnoid hemorrhage in Canada from 1982 through 1991. The Canadian Collaborative Study Group of Stroke Hospitalizations. 
  • Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure: From the ASCEND-HF Trial. 
  • Hospitalization for community-acquired, rotavirus-associated diarrhea: a prospective, longitudinal, population-based study during the seasonal outbreak. The Greater Toronto Area/Peel Region PRESI Study Group. Pediatric Rotavirus Epidemiology Study for Immunization. 
  • Hospitalization outcomes and racial disparities in cervical cancer patients: An analysis of the national inpatient sample data from 2002 to 2014. 
  • Hospitalization rates among survivors of childhood cancer in the Childhood Cancer Survivor Study cohort. 
  • Hospitalization rates before and after adult-to-adult living donor or deceased donor liver transplantation. 
  • Hospitalizations among adults with chronic kidney disease in the United States: A cohort study. 
  • Hospitalizations and Prognosis in Elderly Patients With Heart Failure and Preserved Ejection Fraction: Time to Treat the Whole Patient. 
  • Hospitalizations and return visits after chronic obstructive pulmonary disease ED visits. 
  • Hospitalizations for bacterial septicemia after renal transplantation in the united states. 
  • Hospitalizations for fractures after renal transplantation in the United States. 
  • Hospitalizations for heart failure during the COVID-19 pandemic: making sense of the known knowns, known unknowns, and unknown unknowns. 
  • Hospitalizations in patients with atrial fibrillation: an analysis from ROCKET AF. 
  • Hospitalizations in patients with idiopathic pulmonary fibrosis. 
  • Hospitalized Heart Failure in the United States: Lessons Learned from Clinical Trial Populations. 
  • Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation. 
  • Hospitalized schizophrenic patient views about seclusion. 
  • Host Gene Expression to Predict Sepsis Progression. 
  • How Hospital Stays Resemble Enhanced Interrogation. 
  • How Prepared Are Medical and Nursing Students to Identify Common Hazards in the Intensive Care Unit? 
  • How does autism spectrum disorder affect the risk and severity of childhood asthma? 
  • Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19. 
  • Hyperbaric oxygen therapy in necrotising soft tissue infections: a study of patients in the United States Nationwide Inpatient Sample. 
  • Hyperkalemia and Treatment With RAAS Inhibitors During Acute Heart Failure Hospitalizations and Their Association With Mortality. 
  • Hyperkalemia in hospitalized patients: causes, adequacy of treatment, and results of an attempt to improve physician compliance with published therapy guidelines. 
  • Hypernatremia in hospitalized patients. 
  • Hypochloremia, Diuretic Resistance, and Outcome in Patients With Acute Heart Failure. 
  • Hypokalemia and outcomes in patients with chronic heart failure and chronic kidney disease: findings from propensity-matched studies. 
  • Hyponatremia and Hypotonic Intravenous Fluids Are Associated With Unfavorable Outcomes of Bronchiolitis Admissions. 
  • Hyponatremia and long-term outcomes in chronic heart failure--an observational study from the Duke Databank for Cardiovascular Diseases. 
  • Hypophosphatemia Is More Common and Is Prognostic of Poorer Outcomes in Severe Alcoholic Pancreatitis. 
  • Hypotension during hospitalization for acute heart failure is independently associated with 30-day mortality: findings from ASCEND-HF. 
  • I Brazilian Registry of Heart Failure - Clinical Aspects, Care Quality and Hospitalization Outcomes. 
  • I RBH - First Brazilian Hypertension Registry. 
  • INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support) Profiling Identifies Ambulatory Patients at High Risk on Medical Therapy After Hospitalizations for Heart Failure. 
  • Identification of Patient Characteristics Influencing Setting of Care Decisions for Patients With Acute Bacterial Skin and Skin Structure Infections: Results of a Discrete Choice Experiment. 
  • Identification of borderline personality disorder with the NIMH Diagnostic Interview Schedule. 
  • Identification, diagnosis, treatment, and in-hospital outcomes of acute pulmonary embolism: Results from a single integrated health system. 
  • Identifying frailty in hospitalized older adults with significant coronary artery disease. 
  • Identifying patients at increased risk for poor outcomes from heart failure with reduced ejection fraction: the PROMPT-HF risk model. 
  • Identifying predictors of antimicrobial exposure in hospitalized patients using a machine learning approach. 
  • Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials. 
  • Idiosyncratic Drug Induced Liver Injury in African-Americans Is Associated With Greater Morbidity and Mortality Compared to Caucasians. 
  • Image-guided percutaneous drainage vs. surgical repair of gastrointestinal anastomotic leaks: is there a difference in hospital course or hospitalization cost? 
  • Impact of Accountable Care Organizations on Utilization, Care, and Outcomes: A Systematic Review. 
  • Impact of Age on Comorbidities and Outcomes in Heart Failure With Reduced Ejection Fraction. 
  • Impact of Depression in Sickle Cell Disease Hospitalization-Related Outcomes: An Analysis of the National Inpatient Sample (NIS). 
  • Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death: Outcomes at 4 Years From the Reduction of Atherothrombosis for Continued Health (REACH) Registry. 
  • Impact of Ezetimibe on the Rate of Cardiovascular-Related Hospitalizations and Associated Costs Among Patients With a Recent Acute Coronary Syndrome: Results From the IMPROVE-IT Trial (Improved Reduction of Outcomes: Vytorin Efficacy International Trial). 
  • Impact of High-Deductible Health Plans on Emergency Department Patients With Nonspecific Chest Pain and Their Subsequent Care. 
  • Impact of Medicaid expansion on access and healthcare among individuals with sickle cell disease. 
  • Impact of Medicare Part D on mental health treatment and outcomes for dual eligible beneficiaries with HIV. 
  • Impact of Regionalization of ST-Segment-Elevation Myocardial Infarction Care on Treatment Times and Outcomes for Emergency Medical Services-Transported Patients Presenting to Hospitals With Percutaneous Coronary Intervention: Mission: Lifeline Accelerator-2. 
  • Impact of a Palliative Care Education Module in Patients With Heart Failure. 
  • Impact of a combined pediatric and adult pneumococcal immunization program on adult pneumonia incidence and mortality in Nicaragua. 
  • Impact of a geriatric consultation team on discharge placement and repeat hospitalization. 
  • Impact of an Alcohol Withdrawal Treatment Pathway on Hospital Length of Stay: A Retrospective Observational Study Comparing Pre and Post Pathway Implementation. 
  • Impact of an innovative tuberculosis financing and payment model on health service utilization by tuberculosis patients in China: do the poor fare better than the rich? 
  • Impact of candesartan on nonfatal myocardial infarction and cardiovascular death in patients with heart failure. 
  • Impact of cardiovascular events on change in quality of life and utilities in patients after myocardial infarction: a VALIANT study (valsartan in acute myocardial infarction). 
  • Impact of center volume on outcomes of left ventricular assist device implantation as destination therapy: analysis of the Thoratec HeartMate Registry, 1998 to 2005. 
  • Impact of childhood cancer on healthy school-age siblings. 
  • Impact of chronic antiplatelet therapy before hospitalization on ischemic and bleeding events in invasively managed patients with acute coronary syndromes: the ACUITY trial. 
  • Impact of combined pharmacologic treatment with clopidogrel and a statin on outcomes of patients with non-ST-segment elevation acute coronary syndromes: perspectives from a large multinational registry. 
  • Impact of cuts in acute beds on services for patients. 
  • Impact of depressive symptoms on hospitalization risk in community-dwelling older persons. 
  • Impact of dialysis dose and membrane on infection-related hospitalization and death: results of the HEMO Study. 
  • Impact of exercise-based cardiac rehabilitation in patients with heart failure (ExTraMATCH II) on mortality and hospitalisation: an individual patient data meta-analysis of randomised trials. 
  • Impact of facial fractures and intracranial injuries on hospitalization outcomes following firearm injuries. 
  • Impact of hospitalization for acute coronary events on subsequent mortality in patients with chronic heart failure. 
  • Impact of inappropriate drug use on health services utilization among representative older community-dwelling residents. 
  • Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation-Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). 
  • Impact of patients' psychiatric hospitalization on caregivers: a systematic review. 
  • Impact of rate-modulated pacing on quality of life and exercise capacity--evidence from the Advanced Elements of Pacing Randomized Controlled Trial (ADEPT). 
  • Impact of remote monitoring on clinical events and associated health care utilization: A nationwide assessment. 
  • Impact of renal dysfunction on acute coronary syndrome evaluation in observation unit patients. 
  • Impact of sarcopenia on treatment tolerance in United States veterans with diffuse large B-cell lymphoma treated with CHOP-based chemotherapy. 
  • Impact of school-based health centers on children with asthma. 
  • Impact of serial troponin release on outcomes in patients with acute heart failure: analysis from the PROTECT pilot study. 
  • Impact of specialist follow-up in outpatients with congestive heart failure. 
  • Impact of the NICE guideline recommending cessation of antibiotic prophylaxis for prevention of infective endocarditis: before and after study. 
  • Impact of the heart transplant allocation policy change on inpatient cost of index hospitalization. 
  • Impact of trauma centre capacity and volume on the mortality risk of incoming new admissions. 
  • Impact of underlying malignancy on emergency department utilization and outcomes. 
  • Implantable cardioverter-defibrillator therapy and risk of congestive heart failure or death in MADIT II patients with atrial fibrillation. 
  • Implantable cardioverter-defibrillators in patients hospitalized for heart failure with chronically reduced left ventricular ejection fraction. 
  • Implanted Monitor Alerting to Reduce Treatment Delay in Patients With Acute Coronary Syndrome Events. 
  • Implementation of a Disease Management Program in Adult Patients With Heart Failure. 
  • Implementation of guideline recommendations and outcomes in patients with idiopathic pulmonary fibrosis: Data from the IPF-PRO registry. 
  • Implementing a Prison Medicaid Enrollment Program for Inmates with a Community Inpatient Hospitalization. 
  • Implications of Serum Chloride Homeostasis in Acute Heart Failure (from ROSE-AHF). 
  • Implications of Using Different Definitions on Outcomes in Worsening Heart Failure. 
  • Implications of a recurrent in-hospital cardiac arrest on survival and neurological outcomes. 
  • Implications of elevated cardiac troponin T in ambulatory patients with heart failure: a prospective analysis. 
  • Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. Pediatric Investigators Collaborative Network on Infections in Canada. 
  • Improvement in quality indicators using NCDR® registries: First international experience. 
  • Improvements in Patient and Health System Outcomes Using an Integrated Oncology and Palliative Medicine Approach on a Solid Tumor Inpatient Service. 
  • Improving Care for Patients after Hospitalization with AKI. 
  • Improving Inpatient Care for Individuals with Sickle Cell Disease Using the Project ECHO Model. 
  • Improving Value-Based Care for Left Ventricular Assist Device Therapy: Lowering Costs When Stakes Are High. 
  • Improving functional recovery after critical illness. 
  • Improving implementation of evidence-based therapies for heart failure. 
  • Improving processes of hospital care during the last hours of life. 
  • Improving the Care of Individuals With Sickle Cell Disease in the Emergency Department Using a Quality Improvement Framework: The Emergency Department Sickle Cell Assessment of Needs and Strengths (ED-SCANS). 
  • In HF with LVEF ≤ 42.5%, sacubitril-valsartan vs RAS inhibitors reduced a composite of CV death or HF hospitalization. 
  • In HFpEF, the benefit of empagliflozin on a composite of CV death or HF hospitalization at 26 mo did not vary by diabetes status. 
  • In inpatients with cirrhosis opioid use is common and associated with length of stay and persistent use post-discharge. 
  • In-Hospital Initiation of Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure With Reduced Ejection Fraction. 
  • In-Hospital Mortality and Post-Surgical Complications Among Cancer Patients with Metabolic Syndrome. 
  • In-Hospital Therapy for Heart Failure With Reduced Ejection Fraction in the United States. 
  • In-Hospital and Postdischarge Mortality Among Patients With Acute Decompensated Heart Failure Hospitalizations Ending on the Weekend Versus Weekday: The ARIC Study Community Surveillance. 
  • In-Hospital and Three-Year Outcomes of Heart Failure Patients in South India: The Trivandrum Heart Failure Registry. 
  • In-hospital death following inpatient surgical procedures in the United States, 1996-2006. 
  • In-hospital management of patients with atrial flutter. 
  • In-hospital worsening heart failure and associations with mortality, readmission, and healthcare utilization. 
  • In-hospital worsening heart failure. 
  • Inappropriate medication use among frail elderly inpatients. 
  • Inappropriate prescribing and health outcomes in elderly veteran outpatients. 
  • Incidence and Outcomes of Acute Heart Failure With Preserved Versus Reduced Ejection Fraction in SPRINT. 
  • Incidence and Risk Factors for Intensive Care Unit-related Post-traumatic Stress Disorder in Veterans and Civilians. 
  • Incidence and occurrence of total (first-ever and recurrent) stroke. 
  • Incidence and predictors of all and preventable adverse drug reactions in frail elderly persons after hospital stay. 
  • Incidence of Maternal Sepsis and Sepsis-Related Maternal Deaths in the United States. 
  • Incidence of heart failure and mortality after acute coronary syndromes. 
  • Incidence of mental health hospitalizations, treated self-harm, and emergency room visits following new anxiety disorder diagnoses in privately insured U.S. children. 
  • Incidence of retinopathy of prematurity in the United States: 1997 through 2005. 
  • Incidence of thrombocytopenia among patients receiving heparin venous thromboembolism prophylaxis. 
  • Incidence, Characteristics, and Outcomes of Myocardial Infarction in Patients With Peripheral Artery Disease: Insights From the EUCLID Trial. 
  • Incident stroke and mortality associated with new-onset atrial fibrillation in patients hospitalized with severe sepsis. 
  • Increase in admissions for Neisseria meningitidis infection in Australia. 
  • Increased Risk of Severe Hypoglycemic Events Before and After Cardiovascular Outcomes in TECOS Suggests an At-Risk Type 2 Diabetes Frail Patient Phenotype. 
  • Increased pediatric sub-specialization is associated with decreased surgical complication rates for inpatient pediatric urology procedures. 
  • Increasing Testing for Helicobacter pylori Infection to Improve Quality of Patient Care. 
  • Increasing US rates of endocarditis with Staphylococcus aureus: 1999-2008. 
  • Increasing rates of methicillin-resistant Staphylococcus aureus in academic hospitals: a result of active surveillance? 
  • Incremental value of clinical data beyond claims data in predicting 30-day outcomes after heart failure hospitalization. 
  • Individualizing duration of antibiotic therapy in community-acquired pneumonia. 
  • Infection related never events in pediatric patients undergoing spinal fusion procedures in United States: prevalence and predictors. 
  • Infections after kidney transplantation. Does age matter? 
  • Infective endocarditis and solid organ transplantation: Only worse outcomes during initial transplantation hospitalization. 
  • Inflammatory Markers and Incidence of Hospitalization With Infection in Chronic Kidney Disease. 
  • Influence of Criminal Justice Involvement and Psychiatric Diagnoses on Treatment Costs Among Adults With Serious Mental Illness. 
  • Influence of Patient Goals of Care on Performance Measures in Patients Hospitalized for Heart Failure: An Analysis of the Enhanced Feedback For Effective Cardiac Treatment (EFFECT) Registry. 
  • Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure: results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF). 
  • Influence of atrial fibrillation on post-discharge natriuretic peptide trajectory and clinical outcomes among patients hospitalized for heart failure: insights from the ASTRONAUT trial. 
  • Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: findings from the OPTIMIZE-HF program. 
  • Influence of creatinine versus glomerular filtration rate on non-steroidal anti-inflammatory drug prescriptions in chronic kidney disease. 
  • Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). 
  • Influence of documented history of coronary artery disease on outcomes in patients admitted for worsening heart failure with reduced ejection fraction in the EVEREST trial. 
  • Influence of hospital length of stay for heart failure on quality of care. 
  • Influence of hospitalization for cardiovascular versus noncardiovascular reasons on subsequent mortality in patients with chronic heart failure across the spectrum of ejection fraction. 
  • Influence of inpatient service specialty on care processes and outcomes for patients with non ST-segment elevation acute coronary syndromes. 
  • Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure. 
  • Initial level of care and clinical status in a managed mental health program. 
  • Initiation of Angiotensin-Neprilysin Inhibition After Acute Decompensated Heart Failure: Secondary Analysis of the Open-label Extension of the PIONEER-HF Trial. 
  • Initiation, Continuation, Switching, and Withdrawal of Heart Failure Medical Therapies During Hospitalization. 
  • Initiation, Continuation, or Withdrawal of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction. 
  • Inpatient Ophthalmology Consultations. 
  • Inpatient Use and Outcomes at Children's Hospitals During the Early COVID-19 Pandemic. 
  • Inpatient burden of juvenile dermatomyositis among children in the United States. 
  • Inpatient hospital care for psoriasis: a vanishing practice in the United States. 
  • Inpatient rehabilitation facility discharge destination among younger adults with traumatic brain injury: differences by race and ethnicity. 
  • Insight in schizophrenia and mania. 
  • Institutional experience with voriconazole compared with liposomal amphotericin B as empiric therapy for febrile neutropenia. 
  • Insufficient help for activity of daily living disabilities and risk of all-cause hospitalization. 
  • Insufficient reduction in heart rate during hospitalization despite beta-blocker treatment in acute decompensated heart failure: insights from the ASCEND-HF trial. 
  • Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fraction. 
  • Intensity and focus of heart failure disease management after hospital discharge. 
  • Intensity of End-of-Life Care in a Cohort of Commercially Insured Women With Metastatic Breast Cancer in the United States. 
  • Interactive effect of substance abuse and depression on adolescent social competence. 
  • Intercountry Differences in Guideline-Directed Medical Therapy and Outcomes Among Patients With Heart Failure. 
  • Interhospital transfer status for spinal metastasis patients in the United States is associated with more severe clinical presentations and higher rates of inpatient complications. 
  • Internal Validation of the Sepsis in Obstetrics Score to Identify Risk of Morbidity From Sepsis in Pregnancy. 
  • International Comparison of Poststroke Resource Use: A Longitudinal Analysis in Europe. 
  • International differences in clinical characteristics, management, and outcomes in acute heart failure patients: better short-term outcomes in patients enrolled in Eastern Europe and Russia in the PROTECT trial. 
  • International differences in evolution of early discharge after acute myocardial infarction. 
  • International differences in in-hospital revascularization and outcomes following acute myocardial infarction: a multilevel analysis of patients in ASSENT-2. 
  • International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fraction. 
  • International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia. 
  • International variation in characteristics and clinical outcomes of patients with type 2 diabetes and heart failure: Insights from TECOS. 
  • Interpersonal trauma, war zone exposure, and posttraumatic stress disorder among veterans with schizophrenia. 
  • Intervention Adherence in REHAB-HF: Predictors and Relationship With Physical Function, Quality of Life, and Clinical Events. 
  • Interviews with caregivers during acute asthma hospitalisations. 
  • Intracoronary thrombus and complex morphology in unstable angina. Relation to timing of angiography and in-hospital cardiac events. 
  • Intravenous Migraine Treatment in Children and Adolescents. 
  • Introducing Anti-Vascular Endothelial Growth Factor Therapies for AMD Did Not Raise Risk of Myocardial Infarction, Stroke, and Death. 
  • Invasive bacterial and fungal infections among hospitalized HIV-infected and HIV-uninfected adults and adolescents in northern Tanzania. 
  • Invasive bacterial and fungal infections among hospitalized HIV-infected and HIV-uninfected children and infants in northern Tanzania. 
  • Inverse relationship between body mass index and risk of venous thromboembolism among medically ill hospitalized patients: Observations from the APEX trial. 
  • Inverse relationship of serum albumin to the risk of venous thromboembolism among acutely ill hospitalized patients: Analysis from the APEX trial. 
  • Is Bigger Better?: The Effect of Hospital Consolidation on Index Hospitalization Costs and Outcomes Among Privately Insured Recipients of Immediate Breast Reconstruction. 
  • Is Resistance Futile?: Addressing Diuretic Resistance During Hospitalization for Heart Failure. 
  • Is Time From Last Hospitalization for Heart Failure to Placement of a Primary Prevention Implantable Cardioverter-Defibrillator Associated With Patient Outcomes? 
  • Is bronchial thermoplasty cost-effective as treatment for problematic asthma patients? Singapore's perspective on a global model. 
  • Is hospital procedure volume associated with hospitalization charges and complication rates for cleft lip repairs? 
  • Is rehospitalization after heart failure admission a marker of poor quality? Time for re-evaluation. 
  • Is the APOE epsilon4 genotype associated with higher hospital costs among elderly patients? 
  • Is there a "July effect" for head and neck cancer surgery? 
  • Is there a difference in bloodstream infections in critically ill patients associated with ready-to-use versus compounded parenteral nutrition? 
  • Kidney Function and Outcomes in Patients Hospitalized With Heart Failure. 
  • L-dopa challenge and relapse in schizophrenia. 
  • Laser Ablation of Abnormal Neurological Tissue Using Robotic Neuroblate System (LAANTERN): Procedural Safety and Hospitalization. 
  • Late diagnosis of HIV infection: the role of age and sex. 
  • Late-onset bloodstream infections in hospitalized term infants. 
  • Leading indicators of community-based violent events among adults with mental illness. 
  • Learning from 2523 trauma deaths in India- opportunities to prevent in-hospital deaths. 
  • Left ventricular dysfunction as a risk factor for cardiovascular and noncardiovascular hospitalizations in African Americans. 
  • Left ventricular ejection fraction test rates for Medicare beneficiaries with heart failure. 
  • Left ventricular global longitudinal strain in patients with heart failure with preserved ejection fraction: outcomes following an acute heart failure hospitalization. 
  • Leiomyoma-related hospitalization and surgery: prevalence and predicted growth based on population trends. 
  • Length of hospital stay and 30-day readmission following heart failure hospitalization: insights from the EVEREST trial. 
  • Lessons learned from a clinical trial: Design, rationale, and insights from The Cardiovascular Improvements with Minute Ventilation-targeted Adaptive Sero-Ventilation (ASV) Therapy in Heart Failure (CAT-HF) Study. 
  • Leukotriene modifier use and asthma severity: how is a new medication being used by adults with asthma? 
  • Lifting Coronavirus Disease-19 Shelter-in-Place Restrictions: Impact on Heart Failure Hospitalizations in Northeast Georgia. 
  • Linking inpatient clinical registry data to Medicare claims data using indirect identifiers. 
  • Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines. 
  • Lipid management in patients with unstable angina pectoris and non-ST-segment elevation acute myocardial infarction (from CRUSADE). 
  • Lipid-lowering intensification and low-density lipoprotein cholesterol achievement from hospital admission to 1-year follow-up after an acute coronary syndrome event: results from the Medications ApplIed aNd SusTAINed Over Time (MAINTAIN) registry. 
  • Lipoprotein(a) Testing Patterns in a Large Health System. 
  • Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. 
  • Liver function, in-hospital, and post-discharge clinical outcome in patients with acute heart failure-results from the relaxin for the treatment of patients with acute heart failure study. 
  • Local-Level Immigration Enforcement and Risk of Pediatric Hospitalization for Ambulatory Care Sensitive Conditions. 
  • Long-acting risperidone vs. placebo in the treatment of hospital inpatients with schizophrenia. 
  • Long-term clinical and economic analysis of the Endeavor drug-eluting stent versus the Driver bare-metal stent: 4-year results from the ENDEAVOR II trial (Randomized Controlled Trial to Evaluate the Safety and Efficacy of the Medtronic AVE ABT-578 Eluting Driver Coronary Stent in De Novo Native Coronary Artery Lesions). 
  • Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. 
  • Long-term clinical outcomes of patients with COVID-19 and chronic liver disease: US multicenter COLD study. 
  • Long-term economic outcomes associated with intensive versus moderate lipid-lowering therapy in coronary artery disease: results from the Treating to New Targets (TNT) Trial. 
  • Long-term follow-up of patients with tetralogy of Fallot: physical health and psychopathology. 
  • Long-term healthcare and cost outcomes of disease management in a large, randomized, community-based population with heart failure. 
  • Long-term outcomes and costs of ventricular assist devices among Medicare beneficiaries. 
  • Long-term outcomes associated with hospital acquired thrombocytopenia among patients with non-ST-segment elevation acute coronary syndrome. 
  • Long-term outcomes following development of new-onset atrial fibrillation during sepsis. 
  • Long-term outcomes for heart failure patients with and without diabetes: From the Get With The Guidelines-Heart Failure Registry. 
  • Long-term outcomes in elderly survivors of in-hospital cardiac arrest. 
  • Long-term outcomes of analogue insulin compared with NPH for patients with type 2 diabetes mellitus. 
  • Long-term outcomes of medicare beneficiaries with worsening renal function during hospitalization for heart failure. 
  • Long-term risk of hepatocellular carcinoma mortality in 23220 hospitalized patients treated with micafungin or other parenteral antifungals. 
  • Longitudinal discharge trends and outcomes after hospitalization for mouth cellulitis and Ludwig angina. 
  • Longitudinal medical resources and costs among type 2 diabetes patients participating in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS). 
  • Loop Diuretic Use and Outcomes in Chronic Stable Heart Failure With Preserved Ejection Fraction-Reply. 
  • Loop diuretic dose adjustments after a hospitalization for heart failure: insights from ASCEND-HF. 
  • Loop diuretics in heart failure. 
  • Low health literacy and health outcomes: an updated systematic review. 
  • Lower likelihood of cardiac procedures after acute coronary syndrome in patients with human immunodeficiency virus/acquired immunodeficiency syndrome. 
  • MAO inhibitor therapy in trichotillomania associated with depression: case report. 
  • Major Adverse Limb Events and 1-Year Outcomes After Peripheral Artery Revascularization. 
  • Major depression and physical illness trajectories in heart failure and pulmonary disease. 
  • Major depressive disorder in hospitalized medically ill patients: an examination of young and elderly male veterans. 
  • Management and outcome of patients with atrial fibrillation during acute myocardial infarction: the GUSTO-III experience. Global use of strategies to open occluded coronary arteries. 
  • Management of Atrial Fibrillation in Older Patients by Morbidity Burden: Insights From Get With The Guidelines-Atrial Fibrillation. 
  • Management of Type 1 Diabetes With a Very Low-Carbohydrate Diet. 
  • Management of adolescents and adults with febrile illness in resource limited areas. 
  • Management of heart failure in cardiac amyloidosis using an ambulatory diuresis clinic. 
  • Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial. 
  • Management of pneumonia in the nursing home. 
  • Managing Visitors During the Hospital Stay: The Experience of Family Caregivers of Patients With Traumatic Brain Injury. 
  • Marijuana use and inpatient outcomes among hospitalized patients: analysis of the nationwide inpatient sample database. 
  • Massage reduces anxiety in child and adolescent psychiatric patients. 
  • Matching the environment to patients with delirium: lessons learned from the delirium room, a restraint-free environment for older hospitalized adults with delirium. 
  • Maternal and Fetal Outcomes Associated With Infective Endocarditis in Pregnancy. 
  • Maternal sepsis mortality and morbidity during hospitalization for delivery: temporal trends and independent associations for severe sepsis. 
  • Measuring Adaptive Coping of Hospitalized Patients With a Severe Medical Condition: The Sickness Insight in Coping Questionnaire. 
  • Measuring the effect of policy interventions at the population level: some methodological concerns. 
  • Medicaid Expansion Reduced Uninsured Surgical Hospitalizations And Associated Catastrophic Financial Burden. 
  • Medicaid, managed care, and the care of patients hospitalized for acute myocardial infarction. 
  • Medical Therapy During Hospitalization for Heart Failure With Reduced Ejection Fraction: The VICTORIA Registry. 
  • Medical and Obstetric Outcomes Among Pregnant Women With Congenital Heart Disease. 
  • Medical and infectious complications associated with pyelonephritis among pregnant women at delivery. 
  • Medical chart validation of inpatient diagnosis codes for transfusion-related acute lung injury 2013-2015. 
  • Medical utilization and cost outcomes for poststroke veterans who receive assistive technology devices from the Veterans Health Administration. 
  • Medicare Advantage Plans Pay Hospitals Less Than Traditional Medicare Pays. 
  • Medicare Expenditures by Race/Ethnicity After Hospitalization for Heart Failure With Preserved Ejection Fraction. 
  • Medicare HMO penetration and mortality outcomes of ischemic stroke. 
  • Medicare claims indicators of healthcare utilization differences after hospitalization for ischemic stroke: Race, gender, and caregiving effects. 
  • Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care. 
  • Medication errors in acute cardiac care: An American Heart Association scientific statement from the Council on Clinical Cardiology Subcommittee on Acute Cardiac Care, Council on Cardiopulmonary and Critical Care, Council on Cardiovascular Nursing, and Council on Stroke. 
  • Medication use quality and safety in older adults: 2020 update. 
  • Melatonin and melatonin-receptor agonists to prevent delirium in hospitalized older adults: An umbrella review. 
  • Mental Illness Drives Hospitalizations for Detained California Youth. 
  • Mental health service use by adolescents in the 1970s and 1980s. 
  • Meta-Analysis of Efficacy of Sacubitril/Valsartan in Heart Failure With Preserved Ejection Fraction. 
  • Metaanalysis and review of heart failure disease management randomized controlled clinical trials. 
  • Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 Diabetes. 
  • Metformin use in patients hospitalized with COVID-19: lower inflammation, oxidative stress, and thrombotic risk markers and better clinical outcomes. 
  • Migraines during pregnancy linked to stroke and vascular diseases: US population based case-control study. 
  • Minimally Invasive Versus Open Pancreaticoduodenectomy for Cancer: Practice Patterns and Short-term Outcomes Among 7061 Patients. 
  • Minor depression and physical outcome trajectories in heart failure and pulmonary disease. 
  • Minor depression: a review of the literature. 
  • Missing the True Target in Advanced Heart Failure: It Is Time to Look in the Mirror. 
  • Mode of Death After Acute Heart Failure Hospitalization　- A Clue to Possible Mechanisms. 
  • Mode of death and hospitalization from the Second Follow-up Serial Infusions of Nesiritide (FUSION II) trial and comparison of clinical events committee adjudicated versus investigator reported outcomes. 
  • Modeling zero-modified count and semicontinuous data in health services research Part 1: background and overview. 
  • Moderating Effects of Prior Social Resources on the Hospitalizations of Elders Who Become Widowed 
  • Modest increase in peak VO2 is related to better clinical outcomes in chronic heart failure patients: results from heart failure and a controlled trial to investigate outcomes of exercise training. 
  • Mood variability in adolescents: a study of depressed, nondepressed and comorbid patients. 
  • Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload. 
  • Morbidity of late-season influenza during pregnancy. 
  • Mortality and Macrovascular Risk in Elderly With Hypertension and Diabetes: Effect of Intensive Drug Therapy. 
  • Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials. 
  • Mortality within 24 hours of thrombolysis for myocardial infarction. The importance of early reperfusion. The GUSTO Investigators, Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. 
  • Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. 
  • Most Common Causes of Hospitalization Associated with Inpatient Mortality in the United States Between 2005-2018. 
  • Motor and Cognitive Functional Status Are Associated with 30-day Unplanned Rehospitalization Following Post-Acute Care in Medicare Fee-for-Service Beneficiaries. 
  • Mucositis-related morbidity and resource utilization in head and neck cancer patients receiving radiation therapy with or without chemotherapy. 
  • Multicomorbidity of chronic diseases and substance use disorders and their association with hospitalization: Results from electronic health records data. 
  • Multicomponent interventions for enhancing primary care: a systematic review. 
  • Multinational economic evaluation of valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT). 
  • Multiparameter diagnostic sensor measurements in heart failure patients presenting with SARS-CoV-2 infection. 
  • Multiple cArdiac seNsors for mAnaGEment of Heart Failure (MANAGE-HF) - Phase I Evaluation of the Integration and Safety of the HeartLogic Multisensor Algorithm in Patients With Heart Failure. 
  • N-terminal pro-B-type natriuretic peptide and the risk of stroke among patients hospitalized with acute heart failure: an APEX trial substudy. 
  • NSAID use and association with cardiovascular outcomes in outpatients with stable atherothrombotic disease. 
  • National Trends in End-of-Life Care for Veterans With Advanced Cancer in the Veterans Health Administration: 2009 to 2016. 
  • National trends and characteristics of inpatient detoxification for drug use disorders in the United States. 
  • National trends in health care utilization and racial and socioeconomic disparities in pediatric pyogenic arthritis. 
  • National trends in surgical procedures for degenerative cervical spine disease: 1990-2000. 
  • National trends in the repair of ruptured abdominal aortic aneurysms. 
  • Natural History of Patients Postacute Coronary Syndrome Based on Heart Failure Status. 
  • Navigating the rise of high-deductible health insurance: childbirth in the bronze age. 
  • Neighborhood Socioeconomic Deprivation and 30-Day Mortality and Readmission for Patients Admitted for Diabetes Management. 
  • Nesiritide in patients hospitalized for acute heart failure: does timing matter? Implication for future acute heart failure trials. 
  • Nesiritide, renal function, and associated outcomes during hospitalization for acute decompensated heart failure: results from the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF). 
  • Net economic costs of dementia in Canada. 
  • New Orleans asthma. II. Relationship of climatologic and seasonal factors to outbreaks. 
  • New directions in research on assertive community treatment. 
  • New persistent opioid use after acute opioid prescribing in pregnancy: a nationwide analysis. 
  • New transient ischemic attack and stroke: outpatient management by primary care physicians. 
  • Nocturnal awakenings, sleep environment interruptions, and fatigue in hospitalized children with cancer. 
  • Non-ST-elevation myocardial infarction patients who present during off hours have higher risk profiles and are treated less aggressively, but their outcomes are not worse: a report from Can Rapid Risk Stratification of Unstable Angina Patients Suppress ADverse Outcomes with Early Implementation of the ACC/AHA Guidelines CRUSADE initiative. 
  • Non-operative management of symptomatic cholelithiasis in pregnancy is associated with frequent hospitalizations. 
  • Nonantiretroviral polypharmacy and adverse health outcomes among HIV-infected and uninfected individuals. 
  • Nondisease-specific problems and all-cause mortality among older adults with CKD: the REGARDS Study. 
  • Nonobstructive coronary artery disease and risk of myocardial infarction. 
  • Nosocomial infection rate as a function of human immunodeficiency virus type 1 status in hemophiliacs. 
  • Novel Oral Anticoagulant Use Among Patients With Atrial Fibrillation Hospitalized With Ischemic Stroke or Transient Ischemic Attack. 
  • Novel model for predicting inpatient mortality after emergency admission to hospital in Singapore: retrospective observational study. 
  • OUTpatient intravenous LASix Trial in reducing hospitalization for acute decompensated heart failure (OUTLAST). 
  • Obesity Status and Physical Rehabilitation in Older Patients Hospitalized With Acute HF: Insights From REHAB-HF. 
  • Obesity and its association with comorbidities and hospital charges among patients hospitalized for dental conditions. 
  • Obesity and long-term clinical and economic outcomes in coronary artery disease patients. 
  • Ocular trauma in the United States Army: hospitalization records from 1985 through 1994. 
  • Off-hour admission and in-hospital stroke case fatality in the get with the guidelines-stroke program. 
  • Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: an open-label switch study. 
  • Older adults in North Carolina. A demographic and health status profile. 
  • Older age, aggressiveness of care, and survival for seriously ill, hospitalized adults. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. 
  • One-Year Outcomes and Factors Associated With Mortality Following Acute Myocardial Infarction in Northern Tanzania. 
  • One-year cardiovascular event rates in outpatients with atherothrombosis. 
  • One-year outcome of patients after acute coronary syndromes (from the Canadian Acute Coronary Syndromes Registry). 
  • Open versus minimally invasive surgical approaches in pediatric urology: Trends in utilization and complications. 
  • Operationalizing the Measuring What Matters Spirituality Quality Metric in a Population of Hospitalized, Critically Ill Patients and Their Family Members. 
  • Operative Outcomes of Multiple-Arterial Versus Single-Arterial Coronary Bypass Grafting. 
  • Opioid Abuse and Dependence in Those Hospitalized Due to Head and Neck Cancer. 
  • Opioid abuse/dependence among those hospitalized due to periapical abscess. 
  • Opioid tolerance--a predictor of increased length of stay and higher readmission rates. 
  • Opportunistic cutaneous fungal infections in the inpatient setting. 
  • Optimal Timing to Surgery after Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer. 
  • Optimal timing of intervention in non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Registry. 
  • Orbital fractures: national inpatient trends and complications. 
  • Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design. 
  • Out-of-hospital management of cardiac arrest by basic emergency medical technicians. 
  • Outcome of acute myocardial infarction according to the specialty of the admitting physician. 
  • Outcomes Among Older Patients Receiving Implantable Cardioverter-Defibrillators for Secondary Prevention: From the NCDR ICD Registry. 
  • Outcomes after regional anesthesia. 
  • Outcomes among children and adults at risk of severe dengue in Sri Lanka: Opportunity for outpatient case management in countries with high disease burden. 
  • Outcomes and Anticoagulation Use After Catheter Ablation for Atrial Fibrillation. 
  • Outcomes and cost among Medicare beneficiaries hospitalized for heart failure assigned to accountable care organizations. 
  • Outcomes and health care resource utilization in super-elderly trauma patients. 
  • Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). 
  • Outcomes of COPD Patients with Flame Burn and Inhalation Injuries at a Single Institution. 
  • Outcomes of Children With Critical Bronchiolitis Living in Poor Communities. 
  • Outcomes of Patients With Severe Chronic Lung Disease Who Are Undergoing Transcatheter Aortic Valve Replacement. 
  • Outcomes of Patients with Critical Limb Ischaemia in the EUCLID Trial. 
  • Outcomes of invasive mechanical ventilation in children and adolescents hospitalized due to status asthmaticus in United States: a population based study. 
  • Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. 
  • Outcomes of medicare beneficiaries with heart failure and atrial fibrillation. 
  • Outcomes of patients in clinical trials with ST-segment elevation myocardial infarction among countries with different gross national incomes. 
  • Outcomes of patients with acute coronary syndromes and prior percutaneous coronary intervention: a pooled analysis of three randomized clinical trials. 
  • Outcomes of transcatheter aortic valve replacement for patients with severe aortic stenosis and concomitant aortic insufficiency: Insights from the TVT Registry. 
  • Outpatient care fragmentation in Veterans Affairs patients at high-risk for hospitalization. 
  • Outpatient metformin use is associated with reduced severity of COVID-19 disease in adults with overweight or obesity. 
  • Outpatient versus inpatient worsening heart failure: distinguishing biology and risk from location of care. 
  • Outpatient versus observation/inpatient management of emergency department patients rapidly ruled-out for acute myocardial infarction: Findings from the HIGH-US study. 
  • Overriding psychiatric advance directives: factors associated with psychiatrists' decisions to preempt patients' advance refusal of hospitalization and medication. 
  • PARAGON-HF Clinical Trial Eligibility in a Population of Patients Hospitalized With Heart Failure. 
  • Pain management programs. Clinical and research perspectives. 
  • Palivizumab prophylaxis of respiratory syncytial virus disease in 2000-2001: results from The Palivizumab Outcomes Registry. 
  • Palliative Care Specialist Access is Associated With Rankings of Hospital Quality. 
  • Paramyxovirus Outbreak in a Long-Term Care Facility: The Challenges of Implementing Infection Control Practices in a Congregate Setting. 
  • Participation in a Heart Failure Clinical Trial: Perspectives and Opportunities From the VICTORIA Trial and VICTORIA Simultaneous Registry. 
  • Past personal history of dysphoria, social support, and psychological distress following conjugal bereavement. 
  • Patient Outcomes and Dialysis Consolidation-Two Big to Fail? 
  • Patient Preferences for Medications in Managing Type 2 Diabetes Mellitus: A Discrete Choice Experiment. 
  • Patient Trajectories Among Persons Hospitalized for COVID-19 : A Cohort Study. 
  • Patient and operative factors associated with complications following adolescent idiopathic scoliosis surgery: an analysis of 36,335 patients from the Nationwide Inpatient Sample. 
  • Patient characteristics from a regional multicenter database of acute decompensated heart failure in Asia Pacific (ADHERE International-Asia Pacific). 
  • Patient characteristics, care patterns, and outcomes of atrial fibrillation associated hospitalizations in patients with chronic kidney disease and end-stage renal disease. 
  • Patient journey after admission for acute heart failure: length of stay, 30-day readmission and 90-day mortality. 
  • Patient-Reported Social and Behavioral Determinants of Health and Estimated Risk of Hospitalization in High-Risk Veterans Affairs Patients. 
  • Patient-centered adherence intervention after acute coronary syndrome hospitalization. 
  • Patient-days: a better measure of incidence of occupational bloodborne exposures. 
  • Patient-reported and Clinical Outcomes Among Patients Hospitalized for Heart Failure With Reduced Versus Preserved Ejection Fraction. 
  • Patients Commonly Believe Their Heart Failure Hospitalizations Are Preventable and Identify Worsening Heart Failure, Nonadherence, and a Knowledge Gap as Reasons for Admission. 
  • Patients Hospitalized for De Novo Versus Worsening Chronic Heart Failure in the United States. 
  • Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination. 
  • Patients who want their family and physician to make resuscitation decisions for them: observations from SUPPORT and HELP. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. Hospitalized Elderly Longitudinal Project. 
  • Patients' rights. 
  • Patterns and predictors of evidence-based medication continuation among hospitalized heart failure patients (from Get With the Guidelines-Heart Failure). 
  • Patterns of Care for Atrial Fibrillation Before, During, and at Discharge From Hospitalization: From the Get With The Guidelines-Atrial Fibrillation Registry. 
  • Patterns of amiodarone use and outcomes in clinical practice for atrial fibrillation. 
  • Patterns of antihypertensive treatment in patients with acute severe hypertension from a nonneurologic cause: Studying the Treatment of Acute Hypertension (STAT) registry. 
  • Patterns of cognitive-motor dual-task interference post stroke: an observational inpatient study at hospital discharge. 
  • Patterns of psychological distress in mothers of preterm infants. 
  • Payment source, quality of care, and outcomes in patients hospitalized with heart failure. 
  • Pediatric Cancer in Northern Tanzania: Evaluation of Diagnosis, Treatment, and Outcomes. 
  • Pediatric Traumatic Brain Injury: Families and Healthcare Team Interaction Trajectories During Acute Hospitalization. 
  • Pediatric chronic kidney disease in North Carolina. 
  • Pediatric nurses' perceived knowledge and beliefs of evidence-based practice in the care of children and adolescents with moderate-to-severe traumatic brain injury. 
  • Pediatric traumatic brain injury at Mbarara Regional Referral Hospital, Uganda. 
  • Pelvic inflammatory disease. 
  • Penetration, Completeness, and Representativeness of The Society of Thoracic Surgeons Adult Cardiac Surgery Database. 
  • Performance Assessment of the Universal Vital Assessment Score vs Other Illness Severity Scores for Predicting Risk of In-Hospital Death Among Adult Febrile Inpatients in Northern Tanzania, 2016-2019. 
  • Perioperative morbidity and mortality in combined vs. staged approaches to carotid and coronary revascularization. 
  • Persistence of combat-related posttraumatic stress symptoms for 75 years. 
  • Persistent angina pectoris in ischaemic cardiomyopathy: increased rehospitalization and major adverse cardiac events. 
  • Perspective: Autonomic care systems for hospitalized patients. 
  • Perspectives of individuals with sickle cell disease on barriers to care. 
  • Pharmacist-managed antimicrobial stewardship program for patients discharged from the emergency department. 
  • Pharmacoeconomic analysis of sertraline treatment of depression in patients with unstable angina or a recent myocardial infarction. 
  • Pharmacologic prophylaxis for venous thromboembolism and 30-day outcomes among older patients hospitalized with heart failure: an analysis from the ADHERE national registry linked to Medicare claims. 
  • Pharmacologically treated diabetes and hospitalization among older Norwegians receiving homecare services from 2009 to 2014: a nationwide register study. 
  • Phase III clinical trial end points in acute heart failure syndromes: a virtual roundtable with the Acute Heart Failure Syndromes International Working Group. 
  • Phenome-wide association of 1809 phenotypes and COVID-19 disease progression in the Veterans Health Administration Million Veteran Program. 
  • Physical Activity in the Hospital: Documentation and Influence on Venous Thromboembolism Prophylaxis. 
  • Physical Function, Frailty, Cognition, Depression, and Quality of Life in Hospitalized Adults ≥60 Years With Acute Decompensated Heart Failure With Preserved Versus Reduced Ejection Fraction. 
  • Physical Rehabilitation for Older Patients Hospitalized for Heart Failure. 
  • Physician attitudes toward treatment of depression in older medical inpatients. 
  • Physician prescribing patterns following hospital admission for ischemic cerebrovascular disease. 
  • Physician-diagnosed depression as a correlate of hospitalizations in patients receiving long-term hemodialysis. 
  • Pilot RCT of the Attempted Suicide Short Intervention Program (ASSIP) adapted for rapid delivery during hospitalization to adult suicide attempt patients with substance use problems. 
  • Point-prevalence study of antimicrobial use in public hospitals in southern Sri Lanka identifies opportunities for improving prescribing practices. 
  • Polymicrobial Infections in Hip Arthroplasty: Lower Treatment Success Rate, Increased Surgery, and Longer Hospitalization. 
  • Poor Adherence to Risk Stratification Guidelines Results in Overuse of Venous Thromboembolism Prophylaxis in Hospitalized Older Adults. 
  • Poor Oral Health Linked with Increased Risk of Infectious Complications in Adults with Leukemia. 
  • Population Segmentation Based on Healthcare Needs: Validation of a Brief Clinician-Administered Tool. 
  • Population-based assessment of emergency room visits and hospitalizations among women receiving adjuvant chemotherapy for early breast cancer. 
  • Population-based burden of COPD-related visits in the ED: return ED visits, hospital admissions, and comorbidity risks. 
  • Post-Hospital Outcomes of Patients With Acute Myocardial Infarction With Cardiogenic Shock: Findings From the NCDR. 
  • Post-discharge haemodilution, congestion, and clinical outcomes among patients hospitalized for heart failure with reduced ejection fraction: results from the EVEREST trial. 
  • Post-recovery COVID-19 and incident heart failure in the National COVID Cohort Collaborative (N3C) study. 
  • Post-stroke patients with moderate function have the greatest risk of falls: a National Cohort Study. 
  • Postoperative acute care use after freestanding ambulatory surgery. 
  • Postrelease mortality among persons hospitalized during their incarceration. 
  • Posttraumatic stress disorder symptoms in patients with acute myeloid leukemia. 
  • Potential drug-disease interactions in frail, hospitalized elderly veterans. 
  • Potentially avoidable hospital admissions in older patients with acute myeloid leukaemia in the USA: a retrospective analysis. 
  • Poverty as context for the parenting experience of low-income Lumbee Indian mothers with a medically fragile infant. 
  • Practical and Evidence-Based Approaches to In-Hospital Decongestion for Heart Failure: Are We There Yet? 
  • Practical challenges in the conduct of pragmatic trials embedded in health plans: Lessons of IMPACT-AFib, an FDA-Catalyst trial. 
  • Practice patterns, outcomes, and end-organ dysfunction for patients with acute severe hypertension: the Studying the Treatment of Acute hyperTension (STAT) registry. 
  • Practice standards for electrocardiographic monitoring in hospital settings: an American Heart Association scientific statement from the Councils on Cardiovascular Nursing, Clinical Cardiology, and Cardiovascular Disease in the Young: endorsed by the International Society of Computerized Electrocardiology and the American Association of Critical-Care Nurses. 
  • Practice-Level Variation in Outpatient Cardiac Care and Association With Outcomes. 
  • Prasugrel vs. clopidogrel in acute coronary syndrome patients treated with prasugrel. 
  • Precipitating Clinical Factors, Heart Failure Characterization, and Outcomes in Patients Hospitalized With Heart Failure With Reduced, Borderline, and Preserved Ejection Fraction. 
  • Predialysis health, dialysis timing, and outcomes among older United States adults. 
  • Predicting 6-Month Mortality for Older Adults Hospitalized With Acute Myocardial Infarction: A Cohort Study. 
  • Predicting Emergency Visits and Hospital Admissions During Radiation and Chemoradiation: An Internally Validated Pretreatment Machine Learning Algorithm. 
  • Predicting Outcomes Over Time in Patients With Heart Failure, Left Ventricular Systolic Dysfunction, or Both Following Acute Myocardial Infarction. 
  • Predicting costs among medicare beneficiaries with heart failure. 
  • Predicting freedom from clinical events in non-ST-elevation acute coronary syndromes: the Global Registry of Acute Coronary Events. 
  • Predicting functional status outcomes in hospitalized patients aged 80 years and older. 
  • Predicting long-term mortality in older patients after non-ST-segment elevation myocardial infarction: the CRUSADE long-term mortality model and risk score. 
  • Predicting the cost of illness: a comparison of alternative models applied to stroke. 
  • Predicting the risk of bacteremia in childen with fever and neutropenia. 
  • Prediction of acute respiratory disease in current and former smokers with and without COPD. 
  • Prediction of survival for older hospitalized patients: the HELP survival model. Hospitalized Elderly Longitudinal Project. 
  • Prediction of the extent and severity of left ventricular dysfunction in anterior acute myocardial infarction by the admission electrocardiogram. 
  • Predictors and Associations With Outcomes of Length of Hospital Stay in Patients With Acute Heart Failure: Results From VERITAS. 
  • Predictors of High-Intensity Psychiatric Service Utilization by Veterans Health Administration Patients With Early Psychosis. 
  • Predictors of Hospitalization, Length of Stay, and Cost of Care Among Adults With Dermatomyositis in the United States. 
  • Predictors of Unplanned Hospitalizations Among Older Adults Receiving Cancer Chemotherapy. 
  • Predictors of ambulance transport to first health facility among injured patients in southern Sri Lanka. 
  • Predictors of discharges to a nursing home in a hospital-based cohort. 
  • Predictors of early dyspnoea relief in acute heart failure and the association with 30-day outcomes: findings from ASCEND-HF. 
  • Predictors of hospital length of stay in heart failure: findings from Get With the Guidelines. 
  • Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). 
  • Predictors of incident heart failure hospitalizations among patients with impaired glucose tolerance: insight from the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research study. 
  • Predictors of long-term clinical endpoints in patients with refractory angina. 
  • Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). 
  • Predictors of mortality and morbidity in patients with chronic heart failure. 
  • Predictors of mortality, hospital utilization, and the role of race in outcomes in head and neck trauma. 
  • Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. 
  • Predictors of sudden cardiac death change with time after myocardial infarction: results from the VALIANT trial. 
  • Predictors of suicide attempts: state and trait components. 
  • Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT study. 
  • Predictors of transfusion outcomes in pediatric complex cranial vault reconstruction: a multicentre observational study from the Pediatric Craniofacial Collaborative Group. 
  • Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure. 
  • Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial. 
  • Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. 
  • Preferences for current health and their association with outcomes in patients with kidney disease. 
  • Preferences versus practice: life-sustaining treatments in last months of life in long-term care. 
  • Preoperative chemoradiation for patients with pancreatic cancer: toxicity of endobiliary stents. 
  • Preoperative pain level and patient expectation predict hospital length of stay after total hip arthroplasty. 
  • Preoperative predictors of extended hospital length of stay following total knee arthroplasty. 
  • Prescription of Guideline-Recommended Implantable Cardioverter Defibrillator and Cardiac Resynchronization Therapy Among Patients Hospitalized With Heart Failure and Varying Degrees of Renal Function. 
  • Presence of gingivitis and periodontitis significantly increases hospital charges in patients undergoing heart valve surgery. 
  • Preterm premature rupture of membrane management--inpatient versus outpatient: a retrospective review. 
  • Prevalence and Prognostic Significance of Left Ventricular Noncompaction in Patients Referred for Cardiac Magnetic Resonance Imaging. 
  • Prevalence and Prognostic Significance of Polyvascular Disease in Patients Hospitalized With Acute Decompensated Heart Failure: The ARIC Study. 
  • Prevalence and predictors of complications following facial reconstruction procedures. 
  • Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programme. 
  • Prevalence and prognostic importance of precipitating factors leading to heart failure hospitalization: recurrent hospitalizations and mortality. 
  • Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry. 
  • Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia. 
  • Prevalence and sociodemographic factors associated with depression among hospitalized patients with head and neck cancer-Results from a national study. 
  • Prevalence estimates and outcomes of mental health conditions in those hospitalized owing to dental conditions. 
  • Prevalence of baseline lipid monitoring in patients prescribed second-generation antipsychotics during their index hospitalization: a retrospective cohort study. 
  • Prevalence, Profile, and Prognosis of Severe Obesity in Contemporary Hospitalized Heart Failure Trial Populations. 
  • Prevalence, Underlying Causes, and Preventability of Sepsis-Associated Mortality in US Acute Care Hospitals. 
  • Prevalence, predictors, and outcomes of methicillin-resistant Staphylococcus aureus infections in patients undergoing major surgical procedures in the United States: a population-based study. 
  • Prevalence, predictors, and outcomes of patients with non-ST-segment elevation myocardial infarction and insignificant coronary artery disease: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE) initiative. 
  • Prevalent digoxin use and subsequent risk of death or hospitalization in ambulatory heart failure patients with a reduced ejection fraction-Findings from the Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) randomized controlled trial. 
  • Preventing Hospitalization in Mild Acute Pancreatitis Using a Clinical Pathway in the Emergency Department. 
  • Prevention of thrombotic risk in hospitalized patients with COVID-19 and hemostasis monitoring. 
  • Primary care physician assistant and advance practice nurses roles: Patient healthcare utilization, unmet need, and satisfaction. 
  • Prior Pacemaker Implantation and Clinical Outcomes in Patients With Heart Failure and Preserved Ejection Fraction. 
  • Prior capacity of patients lacking decision making ability early in hospitalization: implications for advance directive administration. The SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. 
  • Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes. 
  • Probabilistic Readjudication of Heart Failure Hospitalization Events in the PARAGON-HF Study. 
  • Prognostic Interplay Between COVID-19 and Heart Failure With Reduced Ejection Fraction. 
  • Prognostic Role of Prior Heart Failure Hospitalization Among Patients Hospitalized for Worsening Chronic Heart Failure. 
  • Prognostic Significance of Creatinine Increases During an Acute Heart Failure Admission in Patients With and Without Residual Congestion: A Post Hoc Analysis of the PROTECT Data. 
  • Prognostic Utility of a Self-Reported Depression Questionnaire versus Clinician-Based Assessment on Renal Outcomes. 
  • Prognostic Value of Coronary Artery Calcium in the PROMISE Study (Prospective Multicenter Imaging Study for Evaluation of Chest Pain). 
  • Prognostic factors of in-hospital complications after hip fracture surgery: a scoping review. 
  • Prognostic significance of bleeding location and severity among patients with acute coronary syndromes. 
  • Prognostic significance of depression in blacks with heart failure: insights from Heart Failure: a Controlled Trial Investigating Outcomes of Exercise Training. 
  • Prognostic significance of isolated sinus tachycardia during first three days of acute myocardial infarction. 
  • Prognostic value of blood urea nitrogen in patients hospitalized with worsening heart failure: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) study. 
  • Progression of Tricuspid Regurgitation After Surgery for Ischemic Mitral Regurgitation. 
  • Projected Clinical Benefits of Implementation of SGLT-2 Inhibitors Among Medicare Beneficiaries Hospitalized for Heart Failure. 
  • Prolonged progressive hypermetabolism during COVID-19 hospitalization undetected by common predictive energy equations. 
  • Prophylactic colony-stimulating factors in children receiving myelosuppressive chemotherapy: a meta-analysis of randomized controlled trials. 
  • Prospective and External Evaluation of a Machine Learning Model to Predict In-Hospital Mortality of Adults at Time of Admission. 
  • Prospective study of associations among positive emotion and functional status in older patients with coronary artery disease. 
  • Protective and Unequal? Caregiver Presence During Pediatric Hospitalizations. 
  • Protocol for a mixed methods feasibility and implementation study of a community-based integrated care model for home-dwelling older adults: The INSPIRE project. 
  • Providing Rapid Out of Hospital Acute Cardiovascular Treatment 3 (PROACT-3). 
  • Psychiatric morbidity during the early phase of coronary care for myocardial infarction: association with cardiac diagnosis and outcome. 
  • Psychiatric symptomatology and disorders in caregivers of children with asthma. 
  • Psychological functioning of children with insulin-dependent diabetes mellitus: a longitudinal study. 
  • Psychosis in bipolar disorder: phenomenology and impact on morbidity and course of illness. 
  • Psychosocial Experiences of Young Adults Diagnosed With Acute Leukemia During Hospitalization for Induction Chemotherapy Treatment. 
  • Psychosocial Factors, Exercise Adherence, and Outcomes in Heart Failure Patients: Insights From Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION). 
  • Pulmonary artery catheterization in patients with acute coronary syndromes. 
  • Pulmonary function and adverse cardiovascular outcomes: Can cardiac function explain the link? 
  • Pursuing progress in acute coronary syndromes. 
  • Putting the "Optimal" in Optimal Medical Therapy. 
  • Q fever, spotted fever group, and typhus group rickettsioses among hospitalized febrile patients in northern Tanzania. 
  • QRS duration in patients hospitalized for worsening heart failure. 
  • Quality and Safety in Obstetrics and Gynecology. 
  • Quality of Care and Ischemic Stroke Risk After Hospitalization for Transient Ischemic Attack: Findings From Get With The Guidelines-Stroke. 
  • Quality of Care and Outcomes Among Medicare Advantage vs Fee-for-Service Medicare Patients Hospitalized With Heart Failure. 
  • Quality of care and outcomes among patients with acute myocardial infarction by level of kidney function at admission: report from the get with the guidelines coronary artery disease program. 
  • Quality of care of and outcomes for African Americans hospitalized with heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) registry. 
  • Quality of medical care and excess mortality in older patients with mental disorders. 
  • Quantitative cerebral anatomy in depression. A controlled magnetic resonance imaging study. 
  • Race and Insurance Status as Predictors of Bicycle Trauma Outcome in Adults. 
  • Race, exercise training, and outcomes in chronic heart failure: findings from Heart Failure - a Controlled Trial Investigating Outcomes in Exercise TraiNing (HF-ACTION). 
  • Race, resource use, and survival in seriously ill hospitalized adults. The SUPPORT Investigators. 
  • Race/Ethnic Differences in Outcomes Among Hospitalized Medicare Patients With Heart Failure and Preserved Ejection Fraction. 
  • Racial Differences and Temporal Obesity Trends in Heart Failure with Preserved Ejection Fraction. 
  • Racial Differences in Diuretic Efficiency, Plasma Renin, and Rehospitalization in Subjects With Acute Heart Failure. 
  • Racial analysis of patients with myocardial infarction complicated by heart failure and/or left ventricular dysfunction treated with valsartan, captopril, or both. 
  • Racial and Ethnic Differences in Presentation and Outcomes for Patients Hospitalized With COVID-19: Findings From the American Heart Association's COVID-19 Cardiovascular Disease Registry. 
  • Racial and Ethnic Differences in Trajectories of Hospitalization in US Men and Women With Heart Failure. 
  • Racial and socio-economic disparities in breast cancer hospitalization outcomes by insurance status. 
  • Racial differences in hospice use and patterns of care after enrollment in hospice among Medicare beneficiaries with heart failure. 
  • Racial differences in location before hospice enrollment and association with hospice length of stay. 
  • Racial differences in the management of unstable angina: results from the multicenter GUARANTEE registry. 
  • Racial differences in the prevalence and outcomes of atrial fibrillation among patients hospitalized with heart failure. 
  • Racial variations in treatment and outcomes of black and white patients with high-risk non-ST-elevation acute coronary syndromes: insights from CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA Guidelines?). 
  • Racial, ethnic, and affluence differences in elderly patients' use of teaching hospitals. 
  • Racial/Ethnic and Sex Differences in Emergency Medical Services Transport Among Hospitalized US Stroke Patients: Analysis of the National Get With The Guidelines-Stroke Registry. 
  • Racial/Ethnic differences in B-type natriuretic peptide levels and their association with care and outcomes among patients hospitalized with heart failure: findings from Get With The Guidelines-Heart Failure. 
  • Racial/Ethnic differences in process of care and outcomes among patients hospitalized with intracerebral hemorrhage. 
  • Ralph Albert Blakelock (1847-1919): Psychiatric hospitalization and the abduction of an American landscape artist. 
  • Randomised trial of magnesium in in-hospital cardiac arrest. Duke Internal Medicine Housestaff. 
  • Randomised trials of secondary prevention programmes in coronary heart disease: systematic review. 
  • Randomized Trial of Population-Based Clinical Decision Support to Facilitate Care Transitions. 
  • Randomized Trial of Thymectomy in Myasthenia Gravis. 
  • Randomized clinical trial to evaluate a routine full anticoagulation Strategy in Patients with Coronavirus Infection (SARS-CoV2) admitted to hospital: Rationale and design of the ACTION (AntiCoagulaTlon cOroNavirus)-Coalition IV trial. 
  • Randomized elimination and prolongation of ACE inhibitors and ARBs in coronavirus 2019 (REPLACE COVID) Trial Protocol. 
  • Randomized trial of a nurse-administered, telephone-based disease management program for patients with heart failure. 
  • Randomized trial of aspirin, sibrafiban, or both for secondary prevention after acute coronary syndromes. 
  • Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial. 
  • Rapid Response Events in Hospitalized Patients: Patient Symptoms and Clinician Communication. 
  • Rapid assay brain natriuretic peptide and troponin I in patients hospitalized with decompensated heart failure (from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness Trial). 
  • Rapid measurement of total body water to facilitate clinical decision making in hospitalized elderly patients. 
  • Rate, Causes, and Predictors of 30-Day Readmission Following Hospitalization for Acute Pericarditis. 
  • Rates and predictors of rehospitalization among formerly hospitalized adolescents. 
  • Rates of upper gastrointestinal endoscopy and gastro-oesophageal malignancy outcomes. 
  • Rationale and Design of ORCHID: A Randomized Placebo-controlled Clinical Trial of Hydroxychloroquine for Adults Hospitalized with COVID-19. 
  • Rationale and design of ApoA-I Event Reducing in Ischemic Syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute myocardial infarction. 
  • Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF). 
  • Rationale and design of the GRACE (Global Registry of Acute Coronary Events) Project: a multinational registry of patients hospitalized with acute coronary syndromes. 
  • Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the Efficacy of Vasopressin antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST). 
  • Rationale and design of the pilot randomized study of nesiritide versus dobutamine in heart failure (PRESERVD-HF). 
  • Rationale and study design for a multicenter, randomized, double-blind, placebo-controlled study of the effects of tolvaptan on the acute and chronic outcomes of patients hospitalized with worsening congestive heart failure. 
  • Rationale for and design of the TRUE-AHF trial: the effects of ularitide on the short-term clinical course and long-term mortality of patients with acute heart failure. 
  • Re-adjudication of the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) with study-level meta-analysis of hospitalization for heart failure from cardiovascular outcomes trials with dipeptidyl peptidase-4 (DPP-4) inhibitors. 
  • Re: Disproportionate Use of Inpatient Care by Older Adults with Kidney Stones. 
  • Reactive hyperemia is associated with adverse clinical outcomes in heart failure. 
  • Real-Time Surveillance of Influenza Morbidity: Tracking Intensive Care Unit Resource Utilization. 
  • Real-World Comparative Effectiveness and Cost Comparison of Thromboprophylactic Use of Enoxaparin versus Unfractionated Heparin in 376,858 Medically Ill Hospitalized US Patients. 
  • Reasons for warfarin discontinuation in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). 
  • Recent History of Serious Fall Injuries and Posttransplant Outcomes Among US Kidney Transplant Recipients. 
  • Recent nationwide trends in discharge statin treatment of hospitalized patients with stroke. 
  • Recognition and Clinical Presentation of Invasive Fungal Disease in Neonates and Children. 
  • Recurrence of major depressive disorder in hospitalized children and adolescents. 
  • Redefining Cardiac Biomarkers in Predicting Mortality of Inpatients With COVID-19. 
  • Reduced dose intravenous immunoglobulin does not decrease transplant-related complications in adults given related donor marrow allografts. 
  • Reducing Hospitalization in Mild Acute Pancreatitis: Results of Long-term Follow-up. 
  • Refractory status epilepticus in children with and without prior epilepsy or status epilepticus. 
  • Regional differences in clinical profile, quality of care, and outcomes among Hispanic patients hospitalized with acute myocardial infarction in the Get with Guidelines-Coronary Artery Disease (GWTG-CAD) registry. 
  • Regional, age and sex differences in baseline characteristics of patients enrolled in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS). 
  • Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial. 
  • Relation of Angina Pectoris to Outcomes, Quality of Life, and Response to Exercise Training in Patients With Chronic Heart Failure (from HF-ACTION). 
  • Relation of Low Normal Left Ventricular Ejection Fraction to Heart Failure Hospitalization in Blacks (From the Jackson Heart Study). 
  • Relation of dyspnea severity on admission for acute heart failure with outcomes and costs. 
  • Relation of serum magnesium levels and postdischarge outcomes in patients hospitalized for heart failure (from the EVEREST Trial). 
  • Relation of serum uric acid levels and outcomes among patients hospitalized for worsening heart failure with reduced ejection fraction (from the efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan trial). 
  • Relation of serum valproate concentration to response in mania. 
  • Relational processes in heart failure care transitions: A data-driven case report. 
  • Relations of Current and Past Cancer with Severe Outcomes among 104,590 Hospitalized COVID-19 Patients: The COVID EHR Cohort at the University of Wisconsin. 
  • Relationship Between Hospital Characteristics and Early Adoption of Angiotensin-Receptor/Neprilysin Inhibitor Among Eligible Patients Hospitalized for Heart Failure. 
  • Relationship Between Infarct Size and Outcomes Following Primary PCI: Patient-Level Analysis From 10 Randomized Trials. 
  • Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. 
  • Relationship between cardiac rehabilitation and long-term risks of death and myocardial infarction among elderly Medicare beneficiaries. 
  • Relationship between changing patient-reported outcomes and subsequent clinical events in patients with chronic heart failure: insights from HF-ACTION. 
  • Relationship between clinical outcomes and vascular access type among hemodialysis patients with Staphylococcus aureus bacteremia. 
  • Relationship between clinical trial site enrollment with participant characteristics, protocol completion, and outcomes: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) trial. 
  • Relationship between exposure, clinical malaria, and age in an area of changing transmission intensity. 
  • Relationship between galectin-3 levels and mineralocorticoid receptor antagonist use in heart failure: analysis from HF-ACTION. 
  • Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. 
  • Relationship between left ventricular ejection fraction and cardiovascular outcomes following hospitalization for heart failure: insights from the RELAX-AHF-2 trial. 
  • Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials. 
  • Relationship between sex, ejection fraction, and B-type natriuretic peptide levels in patients hospitalized with heart failure and associations with inhospital outcomes: findings from the Get With The Guideline-Heart Failure Registry. 
  • Relationship between timing of trial randomization, protocol completion, and clinical outcomes among patients hospitalized for heart failure: from the ASTRONAUT trial. 
  • Relationship of Cannabis Use Disorder and Irritable Bowel Syndrome (IBS): An Analysis of 6.8 Million Hospitalizations in the United States. 
  • Relationship of beta-blocker dose with outcomes in ambulatory heart failure patients with systolic dysfunction: results from the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) trial. 
  • Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. 
  • Relationship of carbamazepine reduction rate to seizure frequency during inpatient telemetry. 
  • Relationship of clinical case management to hospitalization and service delivery for seriously mentally ill clients. 
  • Relationship of depression to death or hospitalization in patients with heart failure. 
  • Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial. 
  • Relationship of nutritional status to health and societal participation in children with cerebral palsy. 
  • Relationship of right- to left-sided ventricular filling pressures in advanced heart failure: insights from the ESCAPE trial. 
  • Relationships among the TRH, REM latency, and dexamethasone suppression tests: preliminary findings. 
  • Relationships between emerging measures of heart failure processes of care and clinical outcomes. 
  • Relative cost-effectiveness of treatments for adolescent depression: 36-week results from the TADS randomized trial. 
  • Relaxation therapy reduces anxiety in child and adolescent psychiatric patients. 
  • Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure: Insights From Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARESS-HF). 
  • Religion and depression in older medical inpatients. 
  • Religion and remission of depression in medical inpatients with heart failure/pulmonary disease. 
  • Religion, spirituality, and acute care hospitalization and long-term care use by older patients. 
  • Religiosity and remission of depression in medically ill older patients. 
  • Religious attitudes and practices of hospitalized medically ill older adults. 
  • Religious coping and health status in medically ill hospitalized older adults. 
  • Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. 
  • Reply: Factors That May Affect Body Change During and After Hospitalization for Acute Heart Failure. 
  • Report on Racial Disparities in Hospitalized Patients with Hyperglycemia and Diabetes. 
  • Representativeness of the VICTORIA Trial Population in Clinical Practice: Analysis of the PINNACLE Registry. 
  • Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosis. 
  • Resource Use in the Last Year of Life Among Patients Who Died With Versus of Prostate Cancer. 
  • Resource use and cost of initial coronary revascularization. Coronary angioplasty versus coronary bypass surgery. 
  • Resource use and costs of treatment with anticoagulation and antiplatelet agents: results of the WATCH trial economic evaluation. 
  • Resource use in the last 6 months of life among patients with heart failure in Canada. 
  • Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT). 
  • Resource utilization and costs in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme. 
  • Respiratory Compromise as a New Paradigm for the Care of Vulnerable Hospitalized Patients. 
  • Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants. 
  • Respiratory Viral Infection: An Underappreciated Cause of Acute Febrile Illness Admissions in Southern Sri Lanka. 
  • Respiratory syncytial virus hospitalisation trends in children with haemodynamically significant heart disease, 1997-2012. 
  • Response by Kumbhani et al to Letters Regarding Article, "Association Between Hospital Volume, Processes of Care, and Outcomes in Patients Admitted With Heart Failure: Insights From Get With The Guidelines-Heart Failure". 
  • Response to Exercise Training and Outcomes in Patients With Heart Failure and Diabetes Mellitus: Insights From the HF-ACTION Trial. 
  • Response to Letter Regarding "How Should the Rehabilitation Community Prepare for 2019-nCoV?". 
  • Response to Letter Regarding Article, "Temporal Trends and Variation in Early Scheduled Follow-up After a Hospitalization for Heart Failure: Findings from Get With The Guidelines-Heart Failure. 
  • Response to Letter to the Editor: Vitamin D status may help explain racial disparities in breast cancer hospitalization outcomes. 
  • Responsiveness of PROMIS® Pediatric Measures to Hospitalizations for Sickle Pain and Subsequent Recovery. 
  • Restarting the cycle: incidence and predictors of first acute care use after nursing home discharge. 
  • Resting Heart Rate and Long-term Outcomes Among the African American Population: Insights From the Jackson Heart Study. 
  • Results of phase 3 of the CATIE schizophrenia trial. 
  • Results of the Chronic Heart Failure Intervention to Improve MEdication Adherence study: A randomized intervention in high-risk patients. 
  • Retropharyngeal and Parapharyngeal Abscesses Among Children and Adolescents in the United States: Epidemiology and Management Trends, 2003-2012. 
  • Reverse Cardiac Remodeling and Outcome After Initiation of Sacubitril/Valsartan. 
  • Review of literature on aftercare services among children and adolescents. 
  • Review: In HF with iron deficiency, iron supplementation reduces HF admissions and improves cardiac function. 
  • Revisiting the effect of referral bias on the clinical spectrum of infective endocarditis in adults. 
  • Rhythm control versus rate control for atrial fibrillation and heart failure. 
  • Rhythm versus rate control in the contemporary management of atrial fibrillation in-hospital. 
  • Rifampin use and safety in hospitalized infants. 
  • Risk Factor Burden and Long-Term Prognosis of Patients With Premature Coronary Artery Disease. 
  • Risk Factors and Outcomes of Opioid Users with and Without Concurrent Benzodiazepine Use in the North Carolina Medicaid Population. 
  • Risk Factors for Hospital-Acquired Pressure Injury in Surgical Critical Care Patients. 
  • Risk Factors for Hospitalizations Among Older Adults with Gastrointestinal Cancers. 
  • Risk Factors for Severe Opioid-Related Adverse Events in a National Cohort of Medical Hospitalizations. 
  • Risk and timing of hospitalization for febrile neutropenia in patients receiving CHOP, CHOP-R, or CNOP chemotherapy for intermediate-grade non-Hodgkin lymphoma. 
  • Risk factors for hospital admission among older persons with newly diagnosed heart failure: findings from the Cardiovascular Health Study. 
  • Risk factors for in-hospital mortality and prolonged length of stay in older patients with solid tumor malignancies. 
  • Risk factors for mortality and progression to severe COVID-19 disease in the Southeast region in the United States: A report from the SEUS Study Group. 
  • Risk indexes for exacerbations and hospitalizations due to COPD. 
  • Risk of Postpartum Flare Hospitalizations in Patients with Inflammatory Bowel Disease Persists After Six Months. 
  • Risk of Potentially Inappropriate Medications in Adults With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. 
  • Risk of corticosteroid treatment and hospitalization after checkpoint inhibitor and radiation therapy in patients with cancer. 
  • Risk of hospitalized rhabdomyolysis associated with lipid-lowering drugs in a real-world clinical setting. 
  • Risk of mortality in patients with cancer who experience febrile neutropenia. 
  • Risk of venous thromboembolism among hospitalizations of adults with selected autoimmune diseases. 
  • Risk stratification after hospitalization for decompensated heart failure. 
  • Risk stratification for return emergency department visits among high-risk patients. 
  • Risk-based evaluation of efficacy of rolofylline in patients hospitalized with acute heart failure - Post-hoc analysis of the PROTECT trial. 
  • Risks associated with continuation of potentially inappropriate antihypertensive medications in older adults receiving hemodialysis. 
  • Risks, costs, and outcomes of cerebrospinal fluid leaks after pediatric skull fractures: a MarketScan analysis between 2007 and 2015. 
  • Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness. 
  • Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial. 
  • Rotavirus Vaccine and Intussusception Hospitalizations. 
  • Routine Intensive Care Unit Admission Following Liver Resection: What Is the Value Proposition? 
  • Routine laboratory results and thirty day and one-year mortality risk following hospitalization with acute decompensated heart failure. 
  • Rural-urban differences in preventable hospitalizations among community-dwelling veterans with dementia. 
  • Rural-urban outcome differences associated with COVID-19 hospitalizations in North Carolina. 
  • S100B and brain natriuretic peptide predict functional neurological outcome after intracerebral haemorrhage. 
  • SARS-CoV-2 Cardiac Involvement in Young Competitive Athletes. 
  • SARS-CoV-2 viral load is associated with increased disease severity and mortality. 
  • SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials. 
  • Sacubitril/Valsartan Adherence and Postdischarge Outcomes Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction. 
  • Sacubitril/Valsartan in Advanced Heart Failure With Reduced Ejection Fraction: Rationale and Design of the LIFE Trial. 
  • Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention. 
  • Safety of octreotide in hospitalized infants. 
  • Safety, Effectiveness and Exposure-response of Micafungin in Infants: Application of an Established Pharmacokinetics Model to Electronic Health Records. 
  • Same-day Bilateral Total Knee Arthroplasty Did Not Increase 90-day Hospital Returns. 
  • School-age children's fears of medical experiences 
  • Scope of Sacubitril/Valsartan Eligibility After Heart Failure Hospitalization: Findings From the GWTG-HF Registry (Get With The Guidelines-Heart Failure). 
  • Screening for depression in hospitalized elderly medical patients: taking a closer look. 
  • Screening for trauma history on an inpatient affective-disorders unit: a pilot study. 
  • Seasonal Variation of Atrial Fibrillation Admission and Quality of Care in the United States. 
  • Secondhand smoke is associated with more frequent hospitalizations in children with sickle cell disease. 
  • Secular Increases in Spontaneous Subarachnoid Hemorrhage during Pregnancy: A Nationwide Sample Analysis. 
  • Selection of patients for coronary angiography and coronary revascularization early after myocardial infarction: is there evidence for a gender bias? 
  • Self-rated depression scales and screening for major depression in the older hospitalized patient with medical illness. 
  • Self-rated depressive symptoms in medical inpatients: age and racial differences. 
  • Self-rated health and mortality in the high-functioning elderly--a closer look at healthy individuals: MacArthur field study of successful aging. 
  • Separating variability in healthcare practice patterns from random error. 
  • Sequential Evaluation of NT-proBNP in Heart Failure: Insights Into Clinical Outcomes and Efficacy of Vericiguat. 
  • Sequential matched analysis of racial disparities in breast cancer hospitalization outcomes among African American and White patients. 
  • Serious physical illness as a stressor: effects on family use of medical services. 
  • Seriously ill hospitalized adults: do we spend less on older patients? Support Investigators. Study to Understand Prognoses and Preference for Outcomes and Risks of Treatments. 
  • Sertraline treatment of major depression in patients with acute MI or unstable angina. 
  • Serum IgG Levels and Risk of COPD Hospitalization: A Pooled Meta-analysis. 
  • Serum Osmolality and Postdischarge Outcomes After Hospitalization for Heart Failure. 
  • Serum Potassium Levels and Outcome in Acute Heart Failure (Data from the PROTECT and COACH Trials). 
  • Serum chymase levels correlate with severe dengue warning signs and clinical fluid accumulation in hospitalized pediatric patients. 
  • Severe anemia associated with increased risk of death and myocardial ischemia in patients declining blood transfusion. 
  • Severity of functional impairments by race and sex in older patients hospitalized with acute decompensated heart failure. 
  • Sex Differences in Cannabis Use Disorder Diagnosis Involved Hospitalizations in the United States. 
  • Sex Differences in Clinical Course and Patient-Reported Outcomes Among Patients Hospitalized for Heart Failure. 
  • Sex Differences in Functional and CT Angiography Testing in Patients With Suspected Coronary Artery Disease. 
  • Sex and Age Interactions and Differences in Outcomes After Intracerebral Hemorrhage. 
  • Sex and Race/Ethnicity Differences in Implantable Cardioverter-Defibrillator Counseling and Use Among Patients Hospitalized With Heart Failure: Findings from the Get With The Guidelines-Heart Failure Program. 
  • Sex and Race/Ethnicity-Related Disparities in Care and Outcomes After Hospitalization for Coronary Artery Disease Among Older Adults. 
  • Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. 
  • Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. 
  • Sex differences in management and outcomes of patients with type 2 diabetes and cardiovascular disease: A report from TECOS. 
  • Sex differences in the relation of weight loss self-efficacy, binge eating, and depressive symptoms to weight loss success in a residential obesity treatment program. 
  • Sex-Based Differences in Outcomes After Mitral Valve Surgery for Severe Ischemic Mitral Regurgitation: From the Cardiothoracic Surgical Trials Network. 
  • Sex-Differences in Cause of Death for Patients Hospitalized for Heart Failure With Reduced Versus Preserved Ejection Fraction (from the ASCEND-HF Trial). 
  • Sex-Related Differences in Heart Failure With Preserved Ejection Fraction. 
  • Sex-specific acute heart failure phenotypes and outcomes from PROTECT. 
  • Shifting guidelines for myeloid growth factors: applications in cancer chemotherapy. 
  • Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation. 
  • Short- and long-term rehospitalization and mortality for heart failure in 4 racial/ethnic populations. 
  • Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials. 
  • Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. 
  • Short-term risk of liver and renal injury in hospitalized patients using micafungin: a multicentre cohort study. 
  • Sickle cell disease complications: Prevalence and resource utilization. 
  • Significant Morbidity and Mortality Among Hospitalized End-Stage Liver Disease Patients in Medicare. 
  • Simulated Costs of the ASCO Patient-Centered Oncology Payment Model in Medicare Beneficiaries With Newly Diagnosed Advanced Ovarian Cancer. 
  • Simulating the Suicide Prevention Effects of Firearms Restrictions Based on Psychiatric Hospitalization and Treatment Records: Social Benefits and Unintended Adverse Consequences. 
  • Sitagliptin does not reduce the risk of cardiovascular death or hospitalization for heart failure following myocardial infarction in patients with diabetes: observations from TECOS. 
  • Site selection for heart failure clinical trials in the USA. 
  • Site selection in global clinical trials in patients hospitalized for heart failure: perceived problems and potential solutions. 
  • Six-month follow-up of patients with in-hospital thrombocytopenia during heparin-based anticoagulation (from the Complications After Thrombocytopenia Caused by Heparin [CATCH] registry). 
  • Sleep disorder diagnoses and clinical outcomes among hospitalized breast cancer patients: a nationwide inpatient sample study. 
  • Sleep-Wake States and Feeding Progression in Preterm Infants. 
  • Social Rejection and Suicidal Ideation and Attempts among Adolescents Following Hospitalization: a Prospective Study. 
  • Social functioning in urban, predominantly African American, socially disadvantaged patients with first-episode nonaffective psychosis. 
  • Sociodemographic, perinatal, behavioral, and psychosocial predictors of weight retention at 3 and 12 months postpartum. 
  • Socioeconomic trends in hospitalization for multiple sclerosis. 
  • Socioeconomic, Psychosocial and Behavioral Characteristics of Patients Hospitalized With Cardiovascular Disease. 
  • Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease. 
  • Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure. 
  • Specific Infectious Organisms Associated With Poor Outcomes in Treatment for Hip Periprosthetic Infection. 
  • Specificity of administrative coding for older adults with acute heart failure hospitalizations. 
  • Spinal surgery: variations in health care costs and implications for episode-based bundled payments. 
  • Standard care versus protocol based therapy for new onset Pseudomonas aeruginosa in cystic fibrosis. 
  • Standardized definitions for evaluation of heart failure therapies: scientific expert panel from the Heart Failure Collaboratory and Academic Research Consortium. 
  • Statin safety: an assessment using an administrative claims database. 
  • Strategies for improving survival after in-hospital cardiac arrest in the United States: 2013 consensus recommendations: a consensus statement from the American Heart Association. 
  • Stroke in young cannabis users (18-49 years): National trends in hospitalizations and outcomes. 
  • Studies of Pediatric Liver Transplantation (SPLIT): year 2000 outcomes. 
  • Study design implications of death and hospitalization as end points in idiopathic pulmonary fibrosis. 
  • Study of Cardiovascular Health Outcomes in the Era of Claims Data: The Cardiovascular Health Study. 
  • Subgroups of High-Risk Veterans Affairs Patients Based on Social Determinants of Health Predict Risk of Future Hospitalization. 
  • Subjective social support and depressive symptoms in major depression: separate phenomena or epiphenomena. 
  • Substance use among patients with a psychotic disorder in a psychiatric emergency room. 
  • Sudden Death After Hospitalization for Heart Failure With Reduced Ejection Fraction (from the EVEREST Trial). 
  • Sudden cardiac death following admission for acute heart failure: adding insult to injury. 
  • Suicide and Self-Harm in Children and Adolescents Admitted to PICUs in the United States. 
  • Suicide attempts among formerly hospitalized adolescents: a prospective naturalistic study of risk during the first 5 years after discharge. 
  • Summary of evidence regarding hospital strategies to reduce door-to-balloon times for patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. 
  • Surgical Interventions During End-of-Life Hospitalizations in Children's Hospitals. 
  • Survival and health care utilization in elderly medical inpatients with major depression. 
  • Survival benefit of primary prevention implantable cardioverter-defibrillator therapy after myocardial infarction: does time to implant matter? A meta-analysis using patient-level data from 4 clinical trials. 
  • Sustained SBP control and long-term nursing home admission among Medicare beneficiaries. 
  • Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors, and outcomes. 
  • Sustained ventricular arrhythmias and mortality among patients with acute myocardial infarction: results from the GUSTO-III trial. 
  • Symptomatic event reduction with extended-duration betrixaban in acute medically ill hospitalized patients. 
  • Symptoms, Mobility and Function, and Quality of Life in Adults With Acute Leukemia During Initial Hospitalization. 
  • System for High-Intensity Evaluation During Radiation Therapy (SHIELD-RT): A Prospective Randomized Study of Machine Learning-Directed Clinical Evaluations During Radiation and Chemoradiation. 
  • Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. 
  • Systolic blood pressure reduction during the first 24 h in acute heart failure admission: friend or foe? 
  • TRENDS IN THE CARE AND OUTCOMES OF MEDICARE BENEFICIARIES WITH TYPE 2 DIABETES, 2002-2011. 
  • Tales from the frontlines: An alarming rise in hospitalizations related to opioid use disorder in the era of COVID-19. 
  • Target Doses of Heart Failure Medical Therapy and Blood Pressure: Insights From the CHAMP-HF Registry. 
  • Targeting the vulnerable phase of heart failure: initiate novel therapies in stable patients prior to hospitalization. 
  • Team-Based Care for Managing Cardiac Comorbidities in Heart Failure. 
  • Temporal Changes in Postdischarge Mortality Risk After Hospitalization for Heart Failure (from the EVEREST Trial). 
  • Temporal Trends and Prognosis of Physical Examination Findings in Patients With Acute Decompensated Heart Failure: The ARIC Study Community Surveillance. 
  • Temporal Trends in Incidence and Outcomes of Acute Pancreatitis in Hospitalized Patients in the United States From 2002 to 2013. 
  • Temporal Trends in Prevalence and Prognostic Implications of Comorbidities Among Patients With Acute Decompensated Heart Failure: The ARIC Study Community Surveillance. 
  • Temporal Trends of Digoxin Use in Patients Hospitalized With Heart Failure: Analysis From the American Heart Association Get With The Guidelines-Heart Failure Registry. 
  • Temporal trends and factors associated with diabetes mellitus among patients hospitalized with heart failure: Findings from Get With The Guidelines-Heart Failure registry. 
  • Temporal trends in clinical characteristics and in-hospital mortality among patients with COVID-19 in Japan for waves 1, 2, and 3: A retrospective cohort study. 
  • Temporal trends in risk profiles among patients hospitalized for heart failure. 
  • Testing for Coronary Artery Disease in Older Patients With New-Onset Heart Failure: Findings From Get With The Guidelines-Heart Failure. 
  • Texas Medication Algorithm Project: development and feasibility testing of a treatment algorithm for patients with bipolar disorder. 
  • Textbook Outcomes in Liver Transplantation. 
  • The Association of ASA Class on Total Knee and Total Hip Arthroplasty Readmission Rates in an Academic Hospital. 
  • The Association of Digital Health Application Use With Heart Failure Care and Outcomes: Insights From CONNECT-HF. 
  • The Association of Duration of participation in get with the guidelines-resuscitation with quality of Care for in-Hospital Cardiac Arrest. 
  • The Association of Gasoline Prices With Hospital Utilization and Costs for Motorcycle and Nonmotorcycle Motor Vehicle Injuries in the United States. 
  • The Association of Nicotine Replacement Therapy With Outcomes Among Smokers Hospitalized for a Major Surgical Procedure. 
  • The Burden of Congestion in Patients Hospitalized With Acute Decompensated Heart Failure. 
  • The Burden of Hypertension and Diabetes in an Emergency Department in Northern Tanzania. 
  • The China Acute Myocardial Infarction (CAMI) Registry: A national long-term registry-research-education integrated platform for exploring acute myocardial infarction in China. 
  • The Degree of the Predischarge Pulmonary Congestion in Patients Hospitalized for Worsening Heart Failure Predicts Readmission and Mortality. 
  • The Diagnosis and Management of Patients with Renal Colic across a Sample of US Hospitals: High CT Utilization Despite Low Rates of Admission and Inpatient Urologic Intervention. 
  • The Effect of Antidepressants on the Course of Inflammatory Bowel Disease. 
  • The Effect of Clinical Care Location on Clinical Outcomes After Peripheral Vascular Intervention in Medicare Beneficiaries. 
  • The First Brazilian Registry of Hypertension. 
  • The Impact of Depression on Outcomes in Patients With Heart Failure and Reduced Ejection Fraction Treated in the GUIDE-IT Trial. 
  • The Impact of Worsening Heart Failure in the United States. 
  • The Importance of Safety-Net Hospitals in Emergency General Surgery. 
  • The Initiation Management Predischarge Process for Assessment of Carvedilol Therapy for Heart Failure (IMPACT-HF) Study: design and implications. 
  • The NCDR ACTION Registry-GWTG: transforming contemporary acute myocardial infarction clinical care. 
  • The NEECHAM Confusion Scale: construction, validation, and clinical testing. 
  • The Neurobehavioral Cognitive Status Examination: psychometric properties in use with psychiatric inpatients. 
  • The OPTIMIZE patient- and family-centered, primary care-based deprescribing intervention for older adults with dementia or mild cognitive impairment and multiple chronic conditions: study protocol for a pragmatic cluster randomized controlled trial. 
  • The Obesity and Heart Failure Epidemics Among African Americans: Insights From the Jackson Heart Study. 
  • The PROTECT in-hospital risk model: 7-day outcome in patients hospitalized with acute heart failure and renal dysfunction. 
  • The Pilot Randomized Study of Nesiritide Versus Dobutamine in Heart Failure (PRESERVD-HF). 
  • The Public Health Burden of Lymphatic Malformations in Children: National Estimates in the United States, 2000-2009. 
  • The Quality in Australian Health Care Study. 
  • The Role of Family Members in Providing Support For Malawian Women With Preterm Infants During Infant Hospitalization. 
  • The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial. 
  • The Society of Thoracic Surgeons Composite Score for Rating Program Performance for Lobectomy for Lung Cancer. 
  • The Treatment for Adolescents With Depression Study (TADS): demographic and clinical characteristics. 
  • The World Heart Federation Global Study on COVID-19 and Cardiovascular Disease. 
  • The association between meteorological events and acute heart failure: new insights from ASCEND-HF. 
  • The association of admission heart rate and in-hospital cardiovascular events in patients with non-ST-segment elevation acute coronary syndromes: results from 135 164 patients in the CRUSADE quality improvement initiative. 
  • The association of alcohol use with all-cause and cardiovascular disease-related hospitalizations or death in older, high-risk Veterans. 
  • The association of improvement in left ventricular ejection fraction with outcomes in patients with heart failure with reduced ejection fraction: data from CHAMP-HF. 
  • The association of in-hospital major bleeding with short-, intermediate-, and long-term mortality among older patients with non-ST-segment elevation myocardial infarction. 
  • The association of left ventricular ejection fraction with clinical outcomes after myocardial infarction: Findings from the Acute Coronary Treatment and Intervention Outcomes Network (ACTION) Registry-Get With the Guidelines (GWTG) Medicare-linked database. 
  • The association of optimism and perceived discrimination with health care utilization in adults with sickle cell disease. 
  • The association of pre- and posthospital medication adherence in myocardial infarction patients. 
  • The association of the heart failure score with mortality and heart failure hospitalizations in elderly patients: insights from the Mode Selection Trial (MOST). 
  • The burden of dialysis-requiring acute kidney injury among hospitalized adults with HIV infection: a nationwide inpatient sample analysis. 
  • The burden of non-cardiac comorbidities and association with clinical outcomes in an acute heart failure trial - insights from ASCEND-HF. 
  • The chest-pain unit--ready for prime time? 
  • The clinical course of health status and association with outcomes in patients hospitalized for heart failure: insights from ASCEND-HF. 
  • The complexity and cost of drug regimens of older patients hospitalized with heart failure in the United States, 1998-2001. 
  • The contribution of sociodemographic, medical, and attitudinal factors to blood donation among the general public. 
  • The cost of acute myocardial infarction in the new millennium: evidence from a multinational registry. 
  • The costs of fatal and non-fatal falls among older adults. 
  • The course of acute myocardial infarction. Feasibility of early discharge of the uncomplicated patient. 
  • The dexamethasone suppression test in patients with mood disorders. 
  • The economic burden of depression. 
  • The economics of febrile neutropenia: implications for the use of colony-stimulating factors. 
  • The economics of stone disease. 
  • The effect of a nurse-led telephone-based care coordination program on the follow-up and control of cardiovascular risk factors in patients with coronary artery disease. 
  • The effect of filgrastim or pegfilgrastim on survival outcomes of patients with cancer receiving myelosuppressive chemotherapy. 
  • The effect of surgical site infection on older operative patients. 
  • The effect of systematic pediatric care on neonatal mortality and hospitalizations of infants born with oral clefts. 
  • The effect of weight change on nursing care facility admission in the NHANES I Epidemiologic Followup Survey. 
  • The effects of emergency department crowding on triage and hospital admission decisions. 
  • The effects of state psychiatric hospital waitlist policies on length of stay and time to readmission. 
  • The excess burden of stroke in hospitalized adults with sickle cell disease. 
  • The first 20 months of the COVID-19 pandemic: Mortality, intubation and ICU rates among 104,590 patients hospitalized at 21 United States health systems. 
  • The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. 
  • The great imitator: Rocky Mountain spotted fever occurring after hospitalization for unrelated illnesses. 
  • The hospital frailty risk score in patients with heart failure is strongly associated with outcomes but less so with pharmacotherapy. 
  • The impact of arrhythmias in acute heart failure. 
  • The impact of bariatric surgery on the Veterans Administration healthcare system: a cost analysis. 
  • The impact of chronic obstructive pulmonary disease in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST Trial. 
  • The impact of clinical vs administrative claims coding on hospital risk-adjusted outcomes. 
  • The impact of education on caregiver burden on two inpatient oncology units. 
  • The impact of in-hospital complications on the long-term functional outcome of trauma patients: A multicenter study. 
  • The impact of morbid obesity on resource utilization after renal transplantation. 
  • The impact of primary health care on malaria morbidity--defining access by disease burden. 
  • The impact of septicemia occurring during hospitalization for renal transplantation procedures on outcomes in adults in United States. 
  • The impact of the Tsunami on hospitalizations at the tertiary care hospital in the Southern Province of Sri Lanka. 
  • The importance of initial management in the treatment of severe infectious corneal ulcers. 
  • The influence of heart failure on clinical and economic outcomes among older adults ≥75 years of age with acute myocardial infarction. 
  • The knowledge and perceptions of medical personnel relating to outcome after cardiac arrest. 
  • The latent structure of psychiatric symptoms across mental disorders as measured with the PANSS and BPRS-18. 
  • The limited influence of neurosurgeons' behavior on inpatient satisfaction: a retrospective multihospital analysis. 
  • The long and winding road to warfarin pharmacogenetic testing. 
  • The medical costs of gunshot injuries in the United States. 
  • The pathophysiology of acute heart failure--is it all about fluid accumulation? 
  • The potential role of natriuretic peptide-guided management for patients hospitalized for heart failure. 
  • The prognostic significance of heart rate in patients hospitalized for heart failure with reduced ejection fraction in sinus rhythm: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study With Tolvaptan) trial. 
  • The prognostic value of the admission and predischarge electrocardiogram in acute coronary syndromes: the GUSTO-IIb ECG Core Laboratory experience. 
  • The public health resource utilization impact of airway foreign bodies in children. 
  • The real world of de novo heart failure: the next frontier for heart failure clinical trials? 
  • The relationship between violence in Northern Mexico and potentially avoidable hospitalizations in the USA-Mexico border region. 
  • The relationship between workload and length of stay in Singapore. 
  • The relationship of hospital market concentration, costs, and quality for major surgical procedures. 
  • The relationship of social environment, social networks, and health outcomes in the Seattle Longitudinal Study: two analytical approaches. 
  • The role of diazepam loading for the treatment of alcohol withdrawal syndrome in hospitalized patients. 
  • The role of geriatric palliative care in hospitalized older adults. 
  • The safety and efficacy of full- versus reduced-dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended-Duration Betrixaban (APEX) trial. 
  • The safety of an adenosine A(1)-receptor antagonist, rolofylline, in patients with acute heart failure and renal impairment: findings from PROTECT. 
  • The self-reported functional measure: Predictive validity for health care utilization in multiple sclerosis and spinal cord injury. 
  • The spectrum of infection-related morbidity in hospitalized haemodialysis patients. 
  • The structure and structural effects of VA rehabilitation bedservice care for stroke. 
  • The unique supportive care needs of a mother with acute myeloid leukemia during treatment. 
  • The use of GTX as second-line and later chemotherapy for metastatic pancreatic cancer: a retrospective analysis. 
  • The use of animal-assisted therapy in combination with physical therapy in an inpatient rehabilitation facility: A case report. 
  • The use of sodium polystyrene sulfonate in the inpatient management of hyperkalemia. 
  • The utilization of video-conference shared medical appointments in rural diabetes care. 
  • The vulnerable phase after hospitalization for heart failure. 
  • The worst symptom as defined by patients during heart failure hospitalization: implications for response to therapy. 
  • Therapeutic failure-related hospitalisations in the frail elderly. 
  • Therapeutic use of granulocyte colony-stimulating factors for established febrile neutropenia: effect on costs from a hospital perspective. 
  • Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial. 
  • Things We Do for No Reason: Neuroimaging for Hospitalized Patients with Delirium. 
  • Thinking Outside the Box: Treating Acute Heart Failure Outside the Hospital to Improve Care and Reduce Admissions. 
  • Third trimester and early postpartum period of pregnancy have the greatest risk for ACS in women with SCD. 
  • Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry. 
  • Thrombocytopenia in hospitalized patients with severe clostridium difficile infection. 
  • Thrombogenicity markers for early diagnosis and prognosis in COVID-19: a change from the current paradigm? 
  • Thrombolysis in unstable angina. Randomized double-blind trial of t-PA and placebo. 
  • Time from convulsive status epilepticus onset to anticonvulsant administration in children. 
  • Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial. 
  • Timing and Causes of Readmission After Acute Heart Failure Hospitalization-Insights From the Heart Failure Network Trials. 
  • Timing of Treatment Outcomes and Risk Factors for Failure of BPAP in Patients Hospitalized for COPD Exacerbation. 
  • Titration of medical therapy and clinical outcomes among patients with heart failure with reduced ejection fraction: Findings from the HF-ACTION trial. 
  • Tobacco smoke exposure and respiratory morbidity in young children. 
  • Tobacco smoking in patients with heart failure and coronary artery disease: A 20-year experience at Duke University Medical Center. 
  • Tolerability of combined modality therapy for rectal cancer in elderly patients aged 75 years and older. 
  • Tolvaptan in Patients Hospitalized With Acute Heart Failure: Rationale and Design of the TACTICS and the SECRET of CHF Trials. 
  • Top Ten Tips for Palliative Care Clinicians Caring for Heart Failure Patients. 
  • Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial). 
  • Total duration instead of in-hospital antibiotic days: reaching beyond the hospital walls. 
  • Total duration of antimicrobial therapy resulting from inpatient hospitalization. 
  • Toward Reducing COPD Hospitalization. 
  • Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus. 
  • Tracking Patients in Community-Based Palliative Care through the Centers for Medicare & Medicaid Services Healthcare Innovation Project. 
  • Trajectory of Congestion Metrics by Ejection Fraction in Patients With Acute Heart Failure (from the Heart Failure Network). 
  • Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. 
  • Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. 
  • Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial. 
  • Transfusion and mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. 
  • Transient and persistent worsening renal function during hospitalization for acute heart failure. 
  • Transitional adherence and persistence in the use of aldosterone antagonist therapy in patients with heart failure. 
  • Transitional care after hospitalization for acute stroke or myocardial infarction: a systematic review. 
  • Transitions of care interventions to improve quality of life among patients hospitalized with acute conditions: a systematic literature review. 
  • Transplantation of Ex Vivo Expanded Umbilical Cord Blood (NiCord) Decreases Early Infection and Hospitalization. 
  • Treating In-Hospital Stroke. 
  • Treating multidrug-resistant tuberculosis in community settings: a wise investment. 
  • Treatment costs for youths receiving multisystemic therapy or hospitalization after a psychiatric crisis. 
  • Treatment of posttraumatic stress disorder with amitriptyline and placebo. 
  • Treatment of primary liver tumors with Yttrium-90 microspheres (TheraSphere) in high risk patients: analysis of survival and toxicities. 
  • Trend and geographic analysis for traumatic brain injury mortality and cost based on MarketScan database. 
  • Trends Over Time in Drug Administration During Adult In-Hospital Cardiac Arrest. 
  • Trends and Characteristics of Hospitalizations in Patients With Heart Transplant. 
  • Trends and Inpatient Outcomes of Primary Atrial Fibrillation Hospitalizations with Underlying Iron Deficiency Anemia: An Analysis of The National Inpatient Sample Database from 2004 -2018. 
  • Trends and characteristics of hospitalizations for heart failure in the United States from 2004 to 2018. 
  • Trends in Characteristics and Outcomes in Primary Heart Failure Hospitalizations Among Older Population in the United States, 2004 to 2018. 
  • Trends in Characteristics and Outcomes of Peripartum Cardiomyopathy Hospitalizations in the United States Between 2004 and 2018. 
  • Trends in Drug Use-Associated Infective Endocarditis and Heart Valve Surgery, 2007 to 2017: A Study of Statewide Discharge Data. 
  • Trends in HF Hospitalizations Among Young Adults in the United States From 2004 to 2018. 
  • Trends in Noncardiovascular Comorbidities Among Patients Hospitalized for Heart Failure: Insights From the Get With The Guidelines-Heart Failure Registry. 
  • Trends in Readmissions and Length of Stay for Patients Hospitalized With Heart Failure in Canada and the United States. 
  • Trends in Reperfusion Therapy for In-Hospital Ischemic Stroke in the Endovascular Therapy Era. 
  • Trends in Substance Abuse Disorders Among Patients Hospitalized for Heart Failure in the United States. 
  • Trends in Treatment for Patients Hospitalized with Heart Failure with Preserved Ejection Fraction Before and After Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT). 
  • Trends in advanced imaging and hospitalization for emergency department syncope care before and after ACEP clinical policy. 
  • Trends in endocarditis hospitalizations at US children's hospitals: impact of the 2007 American Heart Association Antibiotic Prophylaxis Guidelines. 
  • Trends in hospitalizations for heart failure, acute myocardial infarction, and stroke in the United States from 2004 to 2018. 
  • Trends in infective endocarditis hospitalisations at United States children's hospitals from 2003 to 2014: impact of the 2007 American Heart Association antibiotic prophylaxis guidelines. 
  • Trends in inpatient urinary incontinence surgery in the USA, 1998-2007. 
  • Trends in nonheroin opioid abuse admissions: 1992-2004. 
  • Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes. 
  • Trends in settings for peripheral vascular intervention and the effect of changes in the outpatient prospective payment system. 
  • Trends in the Use of Guideline-Directed Therapies Among Dialysis Patients Hospitalized With Systolic Heart Failure: Findings From the American Heart Association Get With The Guidelines-Heart Failure Program. 
  • Triage after hospitalization with advanced heart failure: the ESCAPE (Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness) risk model and discharge score. 
  • Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease. 
  • Tuberculosis management continues to utilize a large amount of hospital resources in the United States. 
  • Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation. 
  • Two-year outcomes following the HIDOC program: expanding outpatient care delivery to meet the needs of medically complex, high-utilizing patients with a broader interprofessional care team. 
  • US hospitalizations and costs for illicit drug users with soft tissue infections. 
  • Ultrafiltration in Acute Heart Failure: Implications of Ejection Fraction and Early Response to Treatment From CARRESS-HF. 
  • Understanding the Costs Associated With Surgical Care Delivery in the Medicare Population. 
  • Unexplained Variation for Hospitals' Use of Inpatient Rehabilitation and Skilled Nursing Facilities After an Acute Ischemic Stroke. 
  • Unplanned Admissions Following Hip Arthroscopy: Incidence and Risk Factors. 
  • Unplanned hospital admission after ambulatory surgery: a retrospective, single cohort study. 
  • Unrecognised Mycobacterium tuberculosis bacteraemia among hospital inpatients in less developed countries. 
  • Unrepresentative, invalid and misleading: are waiting times for elective admission wrongly calculated? 
  • Unsuspected pulmonary embolism: prospective detection on routine helical CT scans. 
  • Update in hospital palliative care. 
  • Update on Medication Use Quality and Safety in Older Adults, 2017. 
  • Update on aldosterone antagonists use in heart failure with reduced left ventricular ejection fraction. Heart Failure Society of America Guidelines Committee. 
  • Urgent colonoscopy for evaluation and management of acute lower gastrointestinal hemorrhage: a randomized controlled trial. 
  • Urology Consultation and Emergency Department Revisits for Children with Urinary Stone Disease. 
  • Use and 1-year outcomes with conventional and drug-coated balloon angioplasty in patients with lower extremity peripheral artery disease. 
  • Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry. 
  • Use and cost of hospitalization of patients with AD by stage and living arrangement: CERAD XXI. 
  • Use and predictors of heart failure disease management referral in patients hospitalized with heart failure: insights from the Get With the Guidelines Program. 
  • Use of ECT in the United States in 1975, 1980, and 1986. 
  • Use of ED and hospital services for patients with acute leukemia after induction therapy: one year follow-up. 
  • Use of Medicare services before and after introduction of the prospective payment system. 
  • Use of Mobile Health Apps and Wearable Technology to Assess Changes and Predict Pain During Treatment of Acute Pain in Sickle Cell Disease: Feasibility Study. 
  • Use of aldosterone antagonists in heart failure. 
  • Use of and inhospital outcomes after early clopidogrel therapy in patients not undergoing an early invasive strategy for treatment of non-ST-segment elevation myocardial infarction: results from Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association guidelines (CRUSADE). 
  • Use of antidepressants by nonpsychiatrists in the treatment of medically ill hospitalized depressed elderly patients. 
  • Use of biomarkers to establish potential role and function of circulating microRNAs in acute heart failure. 
  • Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network registry. 
  • Use of health services by hospitalized medically ill depressed elderly patients. 
  • Use of hospital services, religious attendance, and religious affiliation. 
  • Use of intensive lipid-lowering therapy in patients hospitalized with acute coronary syndrome: An analysis of 65,396 hospitalizations from 344 hospita participating in Get With The Guidelines (GWTG). 
  • Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States. 
  • Use of nitroglycerin by bolus prevents intensive care unit admission in patients with acute hypertensive heart failure. 
  • Use of physical therapy in patients hospitalized with a diagnosis of generalized weakness: a retrospective study. 
  • Use of ranolazine in patients with incomplete revascularization after percutaneous coronary intervention: design and rationale of the Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (RIVER-PCI) trial. 
  • Usefulness of Noninvasively Measured Pulse Amplitude Changes During the Valsalva Maneuver to Identify Hospitalized Heart Failure Patients at Risk of 30-Day Heart Failure Events (from the PRESSURE-HF Study). 
  • Using diversional activity to enhance coping. 
  • Using electronic health records data to assess comorbidities of substance use and psychiatric diagnoses and treatment settings among adults. 
  • Using physician claims to identify postoperative complications of carotid endarterectomy. 
  • Using the past to predict the future: latent class analysis of patterns of health service use of older adults in the emergency department. 
  • Utility of a clinical risk factor scoring model in predicting infection with extended-spectrum β-lactamase-producing enterobacteriaceae on hospital admission. 
  • Utility of bedside leucocyte esterase testing to rule out septic arthritis. 
  • Utility of biochemical verification of tobacco cessation in the Department of Veterans Affairs. 
  • Utility of predictive tools for risk stratification of elderly individuals with all-cause acute respiratory infection. 
  • Utility of socioeconomic status in predicting 30-day outcomes after heart failure hospitalization. 
  • Utility of the SCL-90-R with depressed and conduct-disordered adolescent inpatients. 
  • Utilization of Implantable Cardioverter Defibrillators Among Patients with a Left Ventricular Assist Device: Insights From a National Database. 
  • Utilization of cardiac resynchronization therapy in eligible patients hospitalized for heart failure and its association with patient outcomes. 
  • Utilization of coronary computed tomography angiography for exclusion of coronary artery disease in ED patients with low- to intermediate-risk chest pain: a 1-year experience. 
  • Utilization of hospice and predicted mortality risk among older patients hospitalized with heart failure: findings from GWTG-HF. 
  • Utilization of spinal cord stimulation in patients with failed back surgery syndrome. 
  • Vaccination Trends in Patients With Heart Failure: Insights From Get With The Guidelines-Heart Failure. 
  • Validation of the WATCH-DM and TRS-HFDM Risk Scores to Predict the Risk of Incident Hospitalization for Heart Failure Among Adults With Type 2 Diabetes: A Multicohort Analysis. 
  • Validity of deterministic record linkage using multiple indirect personal identifiers: linking a large registry to claims data. 
  • Variability in care for children with severe acute asthma in Latin America. 
  • Vasopeptidase inhibitor reduces inhospital costs for patients with congestive heart failure: results from the IMPRESS trial. Inhibition of Metallo Protease by BMS-186716 in a Randomized Exercise and Symptoms Study in Subjects With Heart Failure. 
  • Venous Thromboembolism Risk Assessment and Prophylaxis Use in Pediatric, Adolescent, and Young Adult Hematology Oncology Patients. 
  • Venous thromboembolism among patients hospitalized with COVID-19 at Veterans Health Administration Hospitals. 
  • Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. 
  • Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction. 
  • Village-based distribution of oral rehydration therapy packets in Bangladesh. 
  • Violence and severe mental illness: the effects of substance abuse and nonadherence to medication. 
  • Viral Coinfection is Associated with Improved Outcomes in Emergency Department Patients with SARS-CoV-2. 
  • Vital signs: improving antibiotic use among hospitalized patients. 
  • Vitamin D and prostate cancer: a prediagnostic study with stored sera. 
  • WHO guidelines for antimicrobial treatment in children admitted to hospital in an area of intense Plasmodium falciparum transmission: prospective study. 
  • Warfarin use and outcomes in patients with atrial fibrillation complicating acute coronary syndromes. 
  • Water and sodium in heart failure: a spotlight on congestion. 
  • Weekend hospital admission and discharge for heart failure: association with quality of care and clinical outcomes. 
  • Well-Child Care Attendance and Risk of Asthma Exacerbations. 
  • West Nile virus among hospitalized, febrile patients: a case for expanding diagnostic testing. 
  • What are the risk factors of hospital length of stay in the novel coronavirus pneumonia (COVID-19) patients? A survival analysis in southwest China. 
  • What aspects of hospital culture influence quality? 
  • What is the economic value of digoxin therapy in congestive heart failure patients? Results from the DIG trial. 
  • Where patients with mild to moderate heart failure die: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). 
  • Where to go if not the hospital? Reviewing geriatric bed utilization in an acute care hospital in Singapore. 
  • Wide variation in caffeine discontinuation timing in premature infants. 
  • Withholding medical treatment from the severely demented patient. Decisional processes and cost implications. 
  • Withholding versus withdrawing life-sustaining treatment: patient factors and documentation associated with dialysis decisions. 
  • Within-Trial Evaluation of Medical Resources, Costs, and Quality of Life Among Patients With Type 2 Diabetes Participating in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL). 
  • Working memory and schizophrenia: evidence for slowed encoding. 
  • Worsening Heart Failure Following Admission for Acute Heart Failure: A Pooled Analysis of the PROTECT and RELAX-AHF Studies. 
  • Worsening depressive symptoms are associated with adverse clinical outcomes in patients with heart failure. 
  • Worsening heart failure during hospitalization for acute heart failure: Insights from the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF). 
  • Worsening heart failure, a critical event during hospital admission for acute heart failure: results from the VERITAS study. 
  • Worsening renal function during decongestion among patients hospitalized for heart failure: Findings from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) trial. 
  • [Prognostic value of liver stiffness in decompensated heart failure: results of prospective observational transient elastography-based study]. 
  • β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. 
• 

  Keywords of People

  • Alexander, John Hunter Peel, Professor of Medicine, Medicine, Cardiology
  • Anderson, Ruth A., Professor Emerita in the School of Nursing, School of Nursing
  • Attarian, David Edward, Professor of Orthopaedic Surgery, Orthopaedic Surgery
  • Bettger, Janet Prvu, Adjunct Associate in the Department of Orthopaedic Surgery, Duke Science & Society
  • Bradford, William Dalton, Professor of Pathology, Pathology
  • Clements III, Dennis Alfred, Professor Emeritus of Pediatrics, Pediatrics, General Pediatrics and Adolescent Health
  • Curtis, Lesley H., Professor in Population Health Sciences, Medicine, General Internal Medicine
  • Dement, John McCray, Professor Emeritus in Family Medicine and Community Health, Family Medicine & Community Health,Occupational & Environmental Medicine
  • Grambow, Steven C., Associate Professor of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics
  • Lee, Walter T, Professor of Head and Neck Surgery & Communication Sciences, Radiation Oncology
  • Limkakeng Jr., Alexander Tan, Professor of Emergency Medicine, Emergency Medicine
  • McConnell, Eleanor Schildwachter, Associate Professor in the School of Nursing, School of Nursing
  • Mentz, Robert John, Associate Professor of Medicine, Medicine, Cardiology
  • Milano, Carmelo Alessio, Joseph W. and Dorothy W. Beard Distinguished Professor of Experimental Surgery, Surgery, Cardiovascular and Thoracic Surgery
  • Moehring, Rebekah, Associate Professor of Medicine, Medicine, Infectious Diseases
  • Nielsen, Karen Cristina, Associate Professor of Anesthesiology, Anesthesiology, Ambulatory
  • O'Connor, Christopher Michael, Richard Sean Stack, M.D. Distinguished Professor, Medicine, Clinical Pharmacology
  • Patel, Uptal Dinesh, Adjunct Professor in the Department of Medicine, Medicine, Nephrology
  • Preminger, Glenn Michael, James F. Glenn, M.D. Distinguished Professor of Urology, Surgery, Urology
  • Reed, Shelby Derene, Professor in Population Health Sciences, Duke Science & Society
  • Turner, David Ashley, Consulting Professor in the Department of Pediatrics, Pediatrics, Critical Care Medicine
  • Wu, Li-Tzy, Professor in Psychiatry and Behavioral Sciences, Medicine, General Internal Medicine
  • Yancy Jr., William Samuel, Professor of Medicine, Medicine, General Internal Medicine